WO1998049329A1 - Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance - Google Patents

Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance Download PDF

Info

Publication number
WO1998049329A1
WO1998049329A1 PCT/EP1998/002242 EP9802242W WO9849329A1 WO 1998049329 A1 WO1998049329 A1 WO 1998049329A1 EP 9802242 W EP9802242 W EP 9802242W WO 9849329 A1 WO9849329 A1 WO 9849329A1
Authority
WO
WIPO (PCT)
Prior art keywords
fungicide
plant
plants
expression
polypeptide
Prior art date
Application number
PCT/EP1998/002242
Other languages
German (de)
French (fr)
Inventor
Eberhard Ammermann
Earle Butterfield
Jens Lerchl
Gisela Lorenz
Achim Möller
Udo Rabe
Ralf-Michael Schmidt
Udo Conrad
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL13225298A priority Critical patent/IL132252A0/en
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Priority to SK1372-99A priority patent/SK137299A3/en
Priority to PL98336661A priority patent/PL336661A1/en
Priority to AU73356/98A priority patent/AU737242B2/en
Priority to EA199900889A priority patent/EA199900889A1/en
Priority to EP98920534A priority patent/EP0979295A1/en
Priority to BR9808698-7A priority patent/BR9808698A/en
Priority to JP54654298A priority patent/JP2001523101A/en
Priority to NZ500181A priority patent/NZ500181A/en
Priority to CA002288432A priority patent/CA2288432A1/en
Publication of WO1998049329A1 publication Critical patent/WO1998049329A1/en
Priority to BG103840A priority patent/BG103840A/en
Priority to NO995291A priority patent/NO995291L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Definitions

  • the present invention relates to a method for producing fungicide-tolerant plants by expressing an exogenous one
  • the invention further relates to the use of the corresponding nucleic acids coding for a polypeptide, an antibody or parts of an antibody with fungicide-binding properties in transgenic plants and the transformed in this way
  • Transgenic plants 20 plants are called transgenic plants.
  • Transgenic plants are currently used in various biotechnological areas. Examples are insect-resistant plants (Vaek et al. Plant Cell 5 (1987), 159-169), virus-resistant plants (Powell et al. Science 232 (1986), 738-743) and ozone-resistant plants.
  • the herbicide tolerance is characterized by an increased type or level of tolerance of the plant or of parts of plants to the applied herbicide. This can be accomplished in various ways.
  • the known methods are the use of a metabolism gene such as, for example, the pat gene in connection with glufosinate resistance (WO 8705629) or a target enzyme which is resistant to the herbicide, as in the case of enolpyruvylshikimate -3-phosphate synthase (WO 9204449), which is resistant to 5 glyphosate, and the use of a herbicide in cell and tissue culture for the selection of tolerant plant cells and resulting resistant plants such as acetyl CoA carboxylase Inhibitors described (US 5162602, US 5290696).
  • Antibodies are proteins that are part of the immune system. Common to all antibodies is their spatial, globular structure, the structure of light and heavy chains as well as their basic ability to bind molecules or parts of a molecular structure with high specificity (Alberts et al., In: Molecular Biology of the Cell, 2nd edition 1990, VCH Verlag, ISBN 3-527-27983-0, 1198-1237). Because of these properties, antibodies have been used for a variety of tasks. A distinction is made here between the use of the antibodies in animal and human organisms that produce them, the so-called in-situ applications and the ex-situ applications, i.e. the use of the antibodies after isolation from the producing cells or organisms (Whitelam and Cockburn, TIPS Vol.1, 8 (1996), 268-272).
  • hybrid somatic cell lines haemas
  • somatic cell lines a source of antibodies against very specific antigens
  • Köhler and Milstein Nature 256 (1975) 495-97.
  • This process can be used to produce so-called monoclonal antibodies, which have a uniform structure and are generated by cell fusion.
  • Spleen cells from an immunized mouse are fused with cells from a mouse myeloma. This creates hybridoma cells that proliferate indefinitely. At the same time, the cells secrete specific antibodies against the antigen with which the mouse was immunized.
  • the spleen cells provide the ability to produce antibodies, while the myeloma cells contribute the unlimited growth ability and the continuous antibody secretion.
  • each hybridoma cell is derived from a single B cell as a clone, all of the antibody molecules produced have the same structure, including the antigen binding site. This method has greatly promoted the use of antibodies, as antibodies with a single, known specificity and a homogeneous structure are now available indefinitely. Monoclonal antibodies are widely used in immunodiagnostics and as therapeutic agents.
  • phage display method for producing antibodies has been around for a few years, in which the immune system and the various immunizations in the animal are bypassed.
  • affinity and specificity of the antibody is tailored in vitro (Winter et al., Ann. Rev. Immunol. 12 (1994), 433-455; Hoogenboom TIBTech Vol 15 (1997), 62-70).
  • Gene segments which contain the coding sequence of the variable region of antibodies, ie the antigen binding site are fused with genes for the coat protein of a bacteriophage. Then you infect bacterial with phages containing such fusion genes.
  • the resulting phage particles now have envelopes with the antibody-like fusion protein, with the antibody-binding domain pointing outwards.
  • the phage which contains the desired antibody fragment and specifically binds to a specific antigen can now be isolated from such a phage display library.
  • Each phage isolated in this way produces a monoclonal, antigen-binding polypeptide which corresponds to a monoclonal antibody.
  • the genes for the antigen binding site which are unique for each phage, can be isolated from the phage DNA and used to construct complete antibody genes.
  • antibodies have been used, in particular, as an analytical means ex situ for the qualitative and quantitative detection of antigens. This includes the detection of plant constituents, herbicides or fungicides in drinking water (Sharp et al. (1991) ACS Symp Ser., 446 (Pestic. Resides Food Saf.) 87-95), soil samples (WO 9423018) or in plants or parts of plants, and the use of antibodies
  • Antibodies formed by the plant are supplied to the body from plants or parts of plants suitable for consumption via the mouth, throat or digestive tract and cause effective immune protection. Furthermore, in plants
  • the chemical control of fungi in agronomically important crops requires the use of highly selective fungicides without phytotoxic effects.
  • the phytotoxic effect of fungicides can, for example, be based on an inhibition of plant growth, reduced photosynthetic performance and the associated reduced yield. In some cases
  • the object of the present invention was to develop a novel, generally applicable, genetic engineering method for producing fungicide-tolerant transgenic plants.
  • This object was surprisingly achieved by a method of expressing an exogenous polypeptide, antibody or parts of an antibody with fungicide-binding properties in the plants.
  • a first object of the present invention relates to the production of a fungicide-binding antibody and the cloning of the associated gene or gene fragment.
  • a suitable antibody is first generated that binds the fungicide. This can include by immunizing a vertebrate, usually a mouse, rat, dog, horse, donkey or goat with an antigen.
  • the antigen is a fungicidally active compound that is linked or associated via a functional group to a higher molecular carrier such as bovine serum albumin (BSA), chicken egg white (ovalbumin), keyhole limpet hemocyanin (KLH) or other carriers.
  • BSA bovine serum albumin
  • ovalbumin chicken egg white
  • KLH keyhole limpet hemocyanin
  • This approach initially provides a polyclonal serum that contains antibodies with different specificities.
  • the first approach uses the fusion of antibody-producing cells with cancer cells to form a hybridoma cell culture that constantly produces antibodies, which, by separating the clones it contains, ultimately leads to a homogeneous cell line that produces a defined monoclonal antibody.
  • the cDNA for the antibody or parts of the antibody is isolated from such a monoclonal cell line.
  • These cDNA sequences can then be cloned in expression cassettes and for functional expression in prokaryotic and eukaryotic Organisms, including plants, can be used.
  • phage display banks to select antibodies that bind fungicide molecules and catalytically convert them into a product with non-fungicidal properties.
  • Methods for producing catalytic antibodies are described in Janda et al., Science 275 (1997) 945-948, Chemical selection for catalysis in combinatorial Antibody libraries; Catalytic Antibodies, 1991, Ciba Foundation Symposium 159, Wiley-Interscience Publication.
  • a fungicide-resistant plant can also be produced by cloning the gene of this catalytic antibody and expressing it in a plant.
  • the invention particularly relates to expression cassettes, the coding sequence of which codes for a fungicide-binding polypeptide or its functional equivalent, and their use for producing a fungicide-tolerant plant.
  • the nucleic acid sequence can e.g. be a DNA or a cDNA sequence.
  • Coding sequences suitable for insertion into an expression cassette according to the invention are, for example, those which contain a DNA sequence from a hybridoma cell which codes for a polypeptide with fungicide-binding properties and which thus give the host resistance to certain fungicides.
  • an expression cassette according to the invention also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
  • an expression cassette according to the invention comprises a promoter upstream, ie at the 5 'end of the coding sequence, and downstream, ie at the 3' end, a polyadenylation signal and, if appropriate, further regulatory elements which are associated with the coding sequence in between are operatively linked to the polypeptide with fungicide-binding properties and / or transit peptide.
  • An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
  • sequences preferred but not limited to the operative linkage are targeting sequences to ensure subcellular localization in the apoplast, in the plasma membrane, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil - corpuscles or other compartments and translation enhancers such as the 5 'leadership sequence from the tobacco mosaic virus (Gallie et
  • An expression cassette according to the invention is produced by fusing a suitable promoter with a suitable polypeptide DNA and preferably a DNA coding for a chloroplast-specific transit peptide and a polyadenylation signal inserted between the promoter and polypeptide DNA and a polyadenylation signal according to common recombination and cloning techniques, such as, for example in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W.
  • sequences which ensure targeting in the apoplasts, plastids, the vacuole, in the plasma membrane, the mitochondrium, the endoplasmic reticulum (ER) or by a lack of corresponding operative sequences, ensuring that they remain in the compartment of formation, the cytosol (Kermode , Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Localization in the ER and in the cell wall has proven to be particularly beneficial for the amount of protein accumulation in transgenic plants (Schouten et al., Plant Mol. Biol. 30 (1996), 781-792; Artsaenko et al., Plant J. 8 ( 1995) 745-750).
  • the invention also relates to expression cassettes, the coding sequence of which codes for a fungicide-binding fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
  • Chloroplast-specific transit peptides which are split off enzymatically from the fungicide-binding polypeptide part after transposition of the fungicide-binding polypeptide into the plant chloroplasts are particularly preferred.
  • the transit peptide is particularly preferably derived from plastidic transketolase (TK) or a functional equivalent of this transit peptide (e.g. the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase).
  • the polypeptide DNA or cDNA required for the production of expression cassettes according to the invention is preferably amplified with the aid of the polymerase chain reaction (PCR).
  • PCR polymerase chain reaction
  • Methods for DNA amplification by means of PCR are known, for example from Innis et al., PCR Protocols, A Guide to Methods and Applications, Academic Press (1990).
  • the PCR-generated DNA fragments can expediently be checked by sequence analysis to avoid polymerase errors in constructs to be expressed.
  • the inserted nucleotide sequence coding for a fungicide-binding polypeptide can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components. In general, synthetic nucleotide sequences with codons are generated which are preferred by plants
  • the promoter and terminator regions according to the invention should expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence.
  • the linker has 1 to 10, usually 1 to 8, preferably 2 5 to 6 restriction sites.
  • the linker has a size of less than 100 bp, often less than 60 bp, but at least 5 bp within the regulatory ranges.
  • the promoter according to the invention can be both native or homologous and foreign or heterologous to the host plant.
  • the expression cassette according to the invention contains, in the 5 '-3' transcription direction, the promoter according to the invention, any sequence and a region for the transcriptional termination. Different termination areas are interchangeable. 5
  • an expression cassette according to the invention is inserted as an insert in a recombinant vector, the vector DNA of which contains additional functional regulatory signals, for example sequences for replication or integration.
  • Suitable vectors are inter alia in "Methods in Plant Molecular Biology and Biotechnology” (CRC Press), Chap. 6/7, p.71-119 (1993).
  • Cloning techniques can be cloned the expression cassettes according to the invention into suitable vectors that allow their multiplication, for example in E. coli.
  • suitable cloning vectors include pBR332, pUC series, M13mp series and pA-CYC184.
  • Another object of the invention relates to the use of an expression cassette according to the invention for the transformation of plants, plant cells, plant tissues or parts of plants.
  • the aim of the use is preferably to impart resistance to fungicides with phytotoxic activity.
  • the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
  • Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further object of the present invention.
  • transformation The transfer of foreign genes into the genome of a plant is called transformation.
  • the methods described for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic approach with the gene cannon, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and Agrobacterium-mediated gene transfer. The methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu.Rev. Plant Physiol. Plant Molec.Biol.
  • construct to be expressed is preferably cloned into a vector which is suitable for transcribing Agrobacterium tumefaciens form, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).
  • Agrobacteria transformed with an expression cassette according to the invention can then be used in a known manner to transform plants, in particular crop plants, such as cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various bush, tree, nut and wine species, such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly importantly used in vines, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • crop plants such as cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various bush, tree, nut and wine species, such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly importantly used in vines, for example by bathing wounded
  • Functionally equivalent sequences which encode a fungicide-binding polypeptide are, according to the invention, those sequences which, despite a different nucleotide sequence, still have the desired functions.
  • Functional equivalents thus include naturally occurring variants of the sequences described herein as well as artificial, e.g. Artificial nucleotide sequences obtained by chemical synthesis and adapted to the codon usage of a plant.
  • a functional equivalent is understood to mean, in particular, natural or artificial mutations of an originally isolated sequence encoding the fungicide-binding polypeptide, which furthermore show the desired function. Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues.
  • the present invention also encompasses those nucleotide sequences which are obtained by modification of this nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also the insertion of further restriction enzyme interfaces.
  • Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
  • artificial DNA sequences are suitable as long as, as described above, they impart the desired tolerance to fungicides to avoid phytotoxic effects on crop plants.
  • Such artificial DNA sequences can be constructed, for example, by back-translation using molecular modeling Proteins that have fungicide-binding activity or are determined by in vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence in accordance with the codon usage 5 specific for the host plant are particularly suitable. The specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
  • Sequences are to be called sequences which code for fusion proteins, part of the fusion protein being a non-vegetable fungicide-binding polypeptide or a functionally equivalent part thereof.
  • the second part of the fusion protein may be 5, for example, another polypeptide having enzymatic activity or be an antigenic polypeptide sequence by means of which detection of scFvs expression is possible (for example myc-tag or his-tag).
  • this is preferably a regulatory protein sequence, such as a signal or transit peptide, which directs the polypeptide with fungicide-binding properties to the desired site of action.
  • the invention also relates to the expression products produced according to the invention and to fusion proteins composed of a transit peptide and a polypeptide with fungicide-binding properties.
  • Resistance or tolerance in the context of the present invention means the artificially acquired resistance of plants to fungicides with phytotoxic activity. It includes the partial and, in particular, the complete insensitivity to these inhibitors for at least one generation of plants. 5
  • the phytotoxic site of action of fungicides is generally the leaf tissue, so that leaf-specific expression of the exogenous fungicide-binding polypeptide can offer adequate protection.
  • the phytotoxic effect of a fungicide need not be restricted to the leaf tissue, but can also be tissue-specific in all other parts of the plant.
  • constitutive expression of the exogenous fungicide-binding polypeptide is advantageous.
  • inducible expression may also appear desirable.
  • the efficacy of the transgenically expressed polypeptide with fungicide-binding properties can be determined, for example, in vitro by increasing the number of shoots on fungicide-containing medium using graduated series of concentrations or using seed germination tests.
  • a fungicide tolerance of a test plant which has been modified in terms of type and amount can be tested in greenhouse experiments.
  • the invention furthermore relates to transgenic plants, trans- ⁇ formed with an inventive expression cassette, as well as transgenic cells, tissue, parts and propagation material of such plants.
  • Transgenic crop plants such as, for example, cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, Sa 3 lat and the various bush, tree, Nut and wine species such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly important the vine.
  • the transgenic plants, plant cells, tissue or parts can be treated with a fungicide with a phytotoxic effect which inhibits the plant enzymes, as a result of which the plants, cells, tissue or plant parts which have not been successfully transformed die or are damaged.
  • suitable active ingredients are strobilurins, in particular 5 methyl methoxyimino- ⁇ - (o-tolyloxy) -o-tolylacetate (BAS 490F), and metabolites and functional derivatives of these compounds.
  • BAS 490F 5 methyl methoxyimino- ⁇ - (o-tolyloxy) -o-tolylacetate
  • the DNA inserted into the expression cassettes according to the invention and coding for a polypeptide with fungicide-binding properties can thus also be used as a selection marker.
  • the present invention offers the advantage that, after induction of a selective resistance of the crop plant to fungicides having a phytotoxic effect, 5 such fungicides can also be used in these crops at higher application rates to control harmful fungi which would otherwise lead to plant damage.
  • Compounds from the following groups can be mentioned as non-limiting examples of such fungicides with phytotoxic activity:
  • Sulfur, dithiocarbamates and their derivatives such as ferridimethyldithiocarbamate, zinc dimethyldithiocarbamate, zinc ethylene bisdithiocarbamate, manganese ethylene bisdithiocarbamate, manganese zinc ethylenediamine bisdithiocarbamate, tetramethylthiammonodiaminodisulfate , Ammonia complex of zinc (N, N '-propylene-bis-dithiocarbamate), Zinc (N, N '-propylenebis-dithiocarbamate), N, N' -polypropylene-bis- (thiocarbamoyl) disulfide;
  • Nitroderivate such as dinitro- (1-methylheptyl) phenylcrotonate, 2-sec-butyl-4, 6-dinitrophenyl-3, 3-dimethylacrylate, 2-sec-butyl-4, 6-dinitrophenyl-isopropyl carbonate, 5- Di-isopropyl nitro-isophthalate;
  • Heterocyclic substances such as 2-heptadecyl-2-imidazoline acetate, 2,4-dichloro-6- (o-chloroanilino) -s-triazine, 0.0-diethyl-phthalimidophosphonothioate, 5-amino-l- [ bis- (dimethylamino) - phosphinyl] -3-phenyl-l, 2, 4-triazole, 2, 3-dicyano-l, -dithioanthraquinone, 2-thio-l, 3-dithiolo [4, 5-b] quinoxaline, l- (butylcarbamoyl) -2-benzimidazole-carbamic acid methyl ester, 2-methoxycarbonylamino-benzimidazole, 2- (furyl- (2)) -benzimidazole, 2- (thiazolyl- (4)) -benzimidazole, N- (1, 1, 2, 2-tetrachlor
  • Amines such as 2, 6-dimethyl-N-tridecyl-morpholine or its salts, 2, 6-dimethyl-N-cyclododecyl-morpholine or its salts, N- [3- (p-tert-butylphenyl) -2 -methylpropyl] -cis-2, 6-dimethyl-morpholine, N- [3- (p-tert-butylphenyl) -2-methylpropyl] -piperidine, (8- (1, 1-dimethylethyl) -N- ethyl-N-propyl-1,4-dioxaspiro [4.5] decane-2-methanamine,
  • Azoles such as 1- [2- (2,4-dichlorophenyl) -4-ethyl-l, 3-dioxolan-2-yl-ethyl] -IH-l, 2,4-triazole, 1- [2- (2nd , 4-dichlorophenyl) -4-n-propyl-1,3-dioxolan-2-yl-ethyl] -1H-1,2,4-triazole, N- (n-propyl) -N- ( 2, 4, 6-trichlorophenoxyethyl) -N '-imidazol-yl-urea, 1- (4-chlorophenoxy) -3, 3-dimethyl-l- (1H-1, 2, 4-triazol-l-yl) - 2-butanone, 1- (4-chlorophenoxy) -3, 3-dimethyl-l- (1H-1,2, 4-triazol-l-yl) -2-butanol, (2RS, 3RS) - 1-
  • Strobilurins such as methyl-E-methoxyimino- [ ⁇ - (o-tolyloxy) -o-tolyl] acetate, methyl-E-2- ⁇ 2- [6- (2-cyanophenoxy) pyrimidine-4-yloxy ] -phenyl ⁇ -3-methoxyacrylate, methyl-E-methoxyimino- [ ⁇ - (2-phenoxyphenyl)] acetamide, methyl-E-methoxyimino- [ ⁇ - (2, 5-dimethylphenoxy) -o-tolyl] -acetamide,
  • Anilinopyrimidines such as N- (4, 6-dimethylpyrimidin-2-yl) aniline, N- [4-methyl-6- (1-propynyl) pyrimidin-2-yl] aniline,
  • Cinnamic acid amides such as 3- (4-chlorophenyl) -3- (3, 4-dimethoxyphenyl) acrylic morpholide, as well as various fungicides, such as dodecylguanidine acetate, 3- [3- (3, 5-dimethyl-2-oxycyclohexyl) -2 -hydroxyethyl] -glutarimide, N-methyl-, N-ethyl- (4-trifluoromethyl, -2- [3 ', 4' -dimethoxyphenyl] -benzoic acid amide, hexachlorobenzene, DL-methyl-N- (2, 6- dimethyl-phenyl) -N-furoyl (2) -alaninate, DL-N- (2, 6-dimethyl-phenyl) -N- (2'-methoxyacetyl) -alanine-methyl-ester, N- ( 2,6-dimethylphenyl) -N-chloroace
  • FIG. 5 is not restricted to these:
  • the bacterial strains used below (E. coli, XL-I Blue) ⁇ were obtained from Stratagene.
  • the Agrobacterium strain used for plant transformation (Agrobacterium tumefaciens, C58C1 with the plasmid pGV2260 or pGV3850kan) was developed by Deblaere et al. (Nucl. Acids Res. 13 (1985) 4777).
  • the agrobacterial strain LBA4404 (Clontech) or other 5 suitable strains can be used.
  • the vectors pUC19 (Yanish-Perron, Gene 33 (1985), 103-119) pBlues- script SK- (Stratagene), pGEM-T (Promega), pZerO (Invitrogen), pBinl9 (Bevan et al., Nucl Acids Res. 12 (1984) 8711-8720) and pBinAR (Höfgen and Willmitzer, Plant Science 66 (1990) 221-230) 0 .
  • the sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from Pharmacia according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sei. USA 74 (1977), 5463-5467).
  • a 35S CaMV promoter was inserted as an EcoRI-Kpnl fragment (corresponding to nucleotides 6909-7437 of the Cauliflower mosaic virus (Franck et al. Cell 21 (1980) 285).
  • the polyadenylation signal of gene 3 der T-DNA of the Ti plasmid pTiACH5
  • nucleotides 11749-11939 was isolated as a PvuII-HindIII fragment and cloned between the SpHI-HindIII interface of the vector after addition of Sphl linkers to the PvuII interface .
  • the plasmid pBinAR was formed (Höfgen and Willmitzer, Plant Science 66 (1990) 221-230).
  • fungicides are not immunogenic, they have to be attached to a carrier material such as e.g. KLH can be coupled. If there is a reactive group in the molecule, this coupling can take place directly, otherwise a functional function is carried out during the synthesis of the fungicide.
  • a carrier material such as e.g. KLH
  • this modified carrier molecule e.g. Balb / c mice immunized. As soon as there is enough antibody in the serum to bind to the antigen in the ELISA (enzyme
  • 35 linked immunosorbent assay 35 linked immunosorbent assay are detectable, the spleen cells of these animals are removed and fused with myeloma cells in order to cultivate hybrids.
  • fungicide-modified BSA is also used as an antigen to distinguish the immune response against the hapten from the KLH response.
  • Monoclonal antibodies are produced based on known methods, as described, for example, in “Practical Immunology”, Leslie Hudson and Frank Hay, Blackwell Scientific 5 Publications, 1989 or in “Monoclonal Antibodies: Principles and Practice", James Goding, 1983 , Academic Press, Inc., or in "A practical guide to monoclonal antibodies", J. Liddell and A. Cryer, 1991, John Wiley &Sons; or Achim Möller and Franz Emling "Monoconal antibodies against TNF and their use”. European patent EP-A260610.
  • the starting point for the investigation was a monoclonal antibody that specifically recognizes the BAS 490F fungicide and also has a high binding affinity.
  • the selected hybrid cell line is characterized in that the secreted monoclonal antibodies directed against the fungicide antigen BAS 490F have a high affinity and the specific sequences of the immunoglobulins are available (Berek, C. et al., Nature 316, 412- 418, 1985).
  • This monoclonal antibody against BAS 490F 5 was the starting point for the construction of the single-chain antibody fragment (scFv-antiBAS 490F).
  • mRNA was isolated from the hybridoma cells and rewritten into cDNA o.
  • This cDNA served as a template for the amplification of the variable immunoglobulin genes VH and VK with the specific primers VH1 BACK and VH FOR-2 for the heavy chain and VK2 BACK and MJK5 FON X for the light chain (Clackson et al., Nature 352 , 624-628, 1991).
  • the isolated variable immunoglobulin lines were the starting point for the construction of a single-chain antibody fragment (scFv-antiBAS 490F).
  • scFv-antiBAS 490F single-chain antibody fragment
  • three components VH, VK and a linker fragment were combined in a PCR reaction mixture and the scFv-antiBAS 49OF was amplified (Fig. 3).
  • the functional characterization (antigen binding activity) of the constructed scFv-antiBAS 490F gene was carried out after expression in a bacterial system.
  • the scFv-antiBAS 49OF was made using the method of Hoogenboom, H.R. et al., Nucleic Acids Research 19, 4133-4137, 1991 as a soluble antibody fragment in E. coli.
  • the activity and the specificity of the constructed antibody fragment were checked in ELISA tests (Fig. 4).
  • the scFv-antiBAS 490F gene was cloned downstream of the LeB4 promoter.
  • the LeB4 promoter isolated from Vicia faba shows a strictly seed-specific expression of various foreign genes in tobacco (Bäumlein, H. et al., Mol. Gen. Genet. 225, 121-128, 1991).
  • the scFv For this purpose, the antiBAS 490F gene was merged with a signal peptide sequence that fuses entry into the endoplasmic reticulum and the ER retention signal SEKDEL, which ensures that it remains in the ER (Wandelt et al., 1992) (Fig. 5). 5
  • the constructed expression cassette was cloned into the binary vector pGSGLUC 1 (Saito et al., 1990) and transferred into the Agrobacterium strain EHA 101 by electroporation. Recombinant agrobacterial clones were used for the subsequent transformation of x "Nicotiana tabacum. 70-140 tobacco plants were regenerated per construct. From the regenerated transgenic tobacco plants, seeds of various developmental stages were harvested after self-fertilization. From these seeds, the soluble proteins were obtained after extraction in an aqueous buffer system -
  • the constructed scFv-antiBAS 490F gene had a size of approx.
  • variable domains were fused together in the order VH-L-VL.
  • the starting point for the investigations was a single chain antibody fragment against the fungicide BAS 490F (scFv-anti BAS 490F).
  • the functional characterization (antigen binding activity) of this constructed scFv-anti-BAS 490F gene was carried out after expression 0 in a bacterial system and after expression in tobacco leaves. The activity and the specificity of the antibody fragment constructed was checked in ELISA tests.
  • the scFv-antiBAS 490F gene was cloned downstream of the USP promoter.
  • the soluble proteins were obtained after extraction in an aqueous buffer system. Subsequent analyzes (Western blot analyzes and ELISA tests) showed that a maximum accumulation of greater than 2% of biologically active, antigen-binding scFv-antiBAS 490F polypeptide could be achieved in the leaves. The high expression values were determined in adult green leaves, but the antibody fragment could also be detected in senescent leaf material.
  • the PCR amplification of the one-chain antibody cDNA was carried out in a DNA thermal cycler from Perkin Elmer.
  • the reaction mixtures contained 8 ng / ⁇ l of single-stranded template 20 cDNA, 0.5 ⁇ M of the corresponding oligonucleotides,
  • Vector pBluescript was ligated. E. coli XL-I Blue was transformed with the ligation mixture and the plasmid was amplified.
  • E. coli XL-I Blue was transformed with the ligation mixture and the plasmid was amplified.
  • the plasmid pGSGLUC 1 was transformed into Agrobacterium tumefaciens 5 C58Cl: pGV2260.
  • tobacco plants Naturala tabacum cv. Samsun NN
  • a 1:50 dilution of an overnight culture of a positively transformed agrobact colony in Murashige-Skoog medium Physiol. Plant. 15 (1962) 473 ff.
  • 2% sucrose (2MS medium 2% sucrose (2MS medium.
  • Leaf disks of sterile plants (each about 1 cm 2 ) were incubated in a Petri dish with a 1:50 agrobacterial dilution for 5-10 minutes. This was followed by a 2-day incubation in the dark at 25 ° C.
  • the starting point of the investigations was a single-chain antibody fragment expressed against the fungicide BAS 490F (scFv-anti BAS 490F) expressed in tobacco plants.
  • the amount and activity of the synthesized scFv-antiBAS 490F polypeptide were determined in Western blot analyzes and ELISA tests.
  • the foreign gene was controlled under the control of the CaMV 53S promoter as a translation fusion with the LeB4 signal peptide (N-th inal) and the ER retention signal KDEL (C- terminal).
  • the scFv-antiBAS 490F polypeptide was transported into the endoplasmic reticulum, a stable accumulation of high amounts of active antibody fragment was achieved. After harvesting the leaf material, pieces were frozen at -20 ° C (1), lyophilized (2) or dried at room temperature (3).
  • soluble proteins were obtained from the respective leaf material by extraction in an aqueous buffer and the scFv-antiBAS 490F polpypeptide was purified by affinity chromatography. Equal amounts of purified scFv-antiBAS 490F polypeptide (frozen, lyophilized and dried) were used to determine the activity of the antibody fragment (Fig. 6).
  • Fig. 6 A shows the antigen binding activity of the fresh (1), lyophilized (2) and dried leaves (3) of purified scFv-antiBAS 490F polypeptides.
  • Fig. 6 B the respective amounts of scFv-antiBAS 490F protein (about 100 ng), which were used for the ELISA analyzes, are determined by means of Western blot analyzes. The sizes of the protein molecular weight standards are shown on the left. Thereby about the same antigen binding activity was found.
  • Control show a higher tolerance to the fungicide BAS 490F and lower phytotoxic effects.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a method for producing fungicide-tolerant plants by expressing a fungicide-binding antibody therein.

Description

Expression von Fungizid-bindenden Polypeptiden in Pflanzen zur Erzeugung von Fungizidtoleranz Expression of fungicide-binding polypeptides in plants to produce fungicide tolerance
55
Beschreibungdescription
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von fungizidtoleranten Pflanzen durch Expression eines exogenenThe present invention relates to a method for producing fungicide-tolerant plants by expressing an exogenous one
10 Fungizid-bindenden Polypeptides in Pflanzen oder Pflanzenteilen. Die Erfindung betrifft weiterhin die Verwendung der entsprechenden Nukleinsäuren codierend für ein Polypeptid, einen Antikörper oder Teilen eines Antikörpers mit Fungizid-bindenden Eigenschaften in transgenen Pflanzen und die auf diese Weise transformierte10 fungicide-binding polypeptides in plants or parts of plants. The invention further relates to the use of the corresponding nucleic acids coding for a polypeptide, an antibody or parts of an antibody with fungicide-binding properties in transgenic plants and the transformed in this way
15 Pflanze selbst.15 plant itself.
Es ist bekannt, daß mit Hilfe von gentechnischen Verfahren gezielt Fremdgene in das Genom einer Pflanze übertragen werden können. Dieser Prozeß wird als Transformation und die resultierendenIt is known that with the help of genetic engineering methods, specific foreign genes can be transferred into the genome of a plant. This process is called the transformation and the resulting
20 Pflanzen werden als transgene Pflanzen bezeichnet. Transgene Pflanzen werden derzeit in unterschiedlichen biotechnologischen Bereichen eingesetzt. Beispiele sind insektenresistente Pflanzen (Vaek et al . Plant Cell 5 (1987), 159-169), virusresistente Pflanzen (Powell et al . Science 232 (1986), 738-743) und ozonre-20 plants are called transgenic plants. Transgenic plants are currently used in various biotechnological areas. Examples are insect-resistant plants (Vaek et al. Plant Cell 5 (1987), 159-169), virus-resistant plants (Powell et al. Science 232 (1986), 738-743) and ozone-resistant plants.
25 sistente Pflanzen (Van Camp et al . BioTech. 12 (1994), 165-168). Beispiele für gentechnisch erzielte Qualitätssteigerungen sind: Erhöhung der Haltbarkeit von Früchten (Oeller et al. Science 254 (1991), 437-439), Erhöhung der Stärkeproduktion in Kartoffelknollen (Stark et al . Science 242 (1992), 419), Veränderung der25 resistant plants (Van Camp et al. BioTech. 12 (1994), 165-168). Examples of genetically engineered quality improvements are: increasing the shelf life of fruit (Oeller et al. Science 254 (1991), 437-439), increasing the starch production in potato tubers (Stark et al. Science 242 (1992), 419), changing the
30 Stärke- (Visser et al. Mol. Gen. Genet. 225 (1991), 289-296) und ipidzusammensetzung (Voelker et al . Science 257 (1992), 72-74) und Produktion pflanzenfremder Polymere (Poirer et al. Science 256 (1992) , 520-523) .30 starch (Visser et al. Mol. Gen. Genet. 225 (1991), 289-296) and ipid composition (Voelker et al. Science 257 (1992), 72-74) and production of non-plant polymers (Poirer et al. Science 256: 520-523 (1992).
^5 Ein wichtiges Ziel der pflanzenmolekulargenetischen Arbeiten ist die Erzeugung von Herbizidtoleranz. Die Herbizidtoleranz ist gekennzeichnet durch eine in Art oder Höhe gesteigerte Verträglichkeit der Pflanze oder von Pflanzenteilen gegenüber dem applizier- ten Herbizid. Diese kann auf verschiedene Arten bewerkstelligt " werden. Die bekannten Methoden sind die Nutzung eines Metabolismusgens wie z.B. des pat-Gens im Zusammenhang mit der Glufosinat- Resistenz (WO 8705629) oder eines gegenüber dem Herbizid resi- stenten Zielenzym wie im Falle der Enolpyruvylshiki- mat-3-Phosphat-Synthase (WO 9204449) , die resistent ist gegen 5 Glyphosat , sowie die Verwendung eines Herbizids in Zeil- und Gewebekultur zur Selektion toleranter Pflanzenzellen und daraus resultierender resistenter Pflanzen wie bei Acetyl CoA Carboxylase Hemmstoffen beschrieben (US 5162602, US 5290696) .^ 5 An important goal of plant molecular genetic work is the generation of herbicide tolerance. The herbicide tolerance is characterized by an increased type or level of tolerance of the plant or of parts of plants to the applied herbicide. This can be accomplished in various ways. The known methods are the use of a metabolism gene such as, for example, the pat gene in connection with glufosinate resistance (WO 8705629) or a target enzyme which is resistant to the herbicide, as in the case of enolpyruvylshikimate -3-phosphate synthase (WO 9204449), which is resistant to 5 glyphosate, and the use of a herbicide in cell and tissue culture for the selection of tolerant plant cells and resulting resistant plants such as acetyl CoA carboxylase Inhibitors described (US 5162602, US 5290696).
Antikörper sind Proteine als Bestandteil des Immunsystems. Allen Antikörpern gemeinsam ist ihre räumliche, globuläre Struktur, der Aufbau aus leichter und schwerer Kette sowie ihre prinzipielle Fähigkeit, Moleküle oder Teile einer Molekülstruktur mit hoher Spezifität binden zu können (Alberts et al., in: Molekularbiologie der Zelle, 2. Auflage 1990, VCH Verlag, ISBN 3-527-27983-0, 1198-1237) . Aufgrund dieser Eigenschaften wurden Antikörper für vielfältige Aufgaben genutzt. Man unterscheidet dabei die Anwendung der Antikörper im tierischen und menschlichen Organismen, die sie produzieren, die sogenannte in-situ Anwendungen und die ex-situ Anwendungen, d.h. die Nutzung der Antikörper nach Isolierung aus den produzierenden Zellen oder Organismen (Whitelam und Cockburn, TIPS Vol.1 , 8 (1996), 268-272).Antibodies are proteins that are part of the immune system. Common to all antibodies is their spatial, globular structure, the structure of light and heavy chains as well as their basic ability to bind molecules or parts of a molecular structure with high specificity (Alberts et al., In: Molecular Biology of the Cell, 2nd edition 1990, VCH Verlag, ISBN 3-527-27983-0, 1198-1237). Because of these properties, antibodies have been used for a variety of tasks. A distinction is made here between the use of the antibodies in animal and human organisms that produce them, the so-called in-situ applications and the ex-situ applications, i.e. the use of the antibodies after isolation from the producing cells or organisms (Whitelam and Cockburn, TIPS Vol.1, 8 (1996), 268-272).
Die Verwendung hybrider somatischer Zellinien (Hybridomas) als Quelle für Antikörper gegen ganz bestimmte Antigene geht auf Arbeiten von Köhler und Milstein zurück (Nature 256 (1975) 495-97). Nach diesem Verfahren lassen sich sogenannte monoklonalen Antikörper herstellen, die eine einheitliche Struktur besitzen und durch Zellfusion erzeugt werden. Dabei werden Milzzellen einer immunisierten Maus mit Zellen eines Mausmyeloms fusioniert. So entstehen Hybridomazellen, die sich unbegrenzt vermehren. Gleichzeitig sezernieren die Zellen spezifische Antikörper gegen das Antigen, mit dem die Maus immunisiert worden war. Die Milzzellen liefern die Fähigkeit zur Antikörperproduktion, während die Mye- lomzellen die unbegrenzte Wachstumsfähigkeit und die kontinuierliche Antikörpersekretion beisteuern. Da jede Hybridomazelle sich als Klon von einer einzigen B-Zelle ableitet, besitzen alle erzeugten Antikörpermoleküle dieselbe Struktur einschließlich der Antigenbindungsstelle. Diese Methode hat die Anwendung von Antikörpern stark gefördert, da jetzt Antikörper mit einer einzigen, bekannten Spezifität und einer homogenen Struktur unbegrenzt zur Verfügung stehen. Monoklonale Antikörper finden breite Anwendung in der Immundiagnostik und als Therapeutika.The use of hybrid somatic cell lines (hybridomas) as a source of antibodies against very specific antigens goes back to work by Köhler and Milstein (Nature 256 (1975) 495-97). This process can be used to produce so-called monoclonal antibodies, which have a uniform structure and are generated by cell fusion. Spleen cells from an immunized mouse are fused with cells from a mouse myeloma. This creates hybridoma cells that proliferate indefinitely. At the same time, the cells secrete specific antibodies against the antigen with which the mouse was immunized. The spleen cells provide the ability to produce antibodies, while the myeloma cells contribute the unlimited growth ability and the continuous antibody secretion. Since each hybridoma cell is derived from a single B cell as a clone, all of the antibody molecules produced have the same structure, including the antigen binding site. This method has greatly promoted the use of antibodies, as antibodies with a single, known specificity and a homogeneous structure are now available indefinitely. Monoclonal antibodies are widely used in immunodiagnostics and as therapeutic agents.
Seit einigen Jahren gibt es die sogenannte Phagen-Display-Methode zur Herstellung von Antikörpern, bei der das Immunsystem und die verschiedenen Immunisierungen im Tier umgangen werden. Hierbei wird die Affinität und Spezifität des Antikörpers in vitro maßgeschneidert (Winter et al . , Ann. Rev. Immunol . 12 (1994), 433-455; Hoogenboom TIBTech Vol 15 (1997), 62 -70). Gensegmente, die die kodierende Sequenz der variablen Region von Antikörpern enthält, d.h. die Antigen-Bindestelle, werden mit Genen für das Hüllprotein eines Bakteriophagen fusioniert. Dann infiziert man Bakte- rien mit Phagen, die solche Fusionsgene enthalten. Die entstehenden Phagenpartikel besitzen nun Hüllen mit dem antikörperähnlichen Fusionsprotein, wobei die antikörperbindende Domäne nach außen zeigt. Aus einer solchen Phagen-Display-Bibliothek läßt sich 5 nun der Phage isolieren, der das gewünschte Antikörperfragment enthält und spezifisch an ein bestimmtes Antigen bindet. Jeder so isolierte Phage erzeugt ein monoklonales, antigenbindendes Poly- peptid, das einem monoklonalen Antikörper entspricht. Die Gene für die Antigenbindungstelle, die für jeden Phagen einzigartig 10 sind, kann man aus der Phagen-DNA isolieren und zur Konstruktion vollständiger Antikörpergene einsetzen.The so-called phage display method for producing antibodies has been around for a few years, in which the immune system and the various immunizations in the animal are bypassed. Here, the affinity and specificity of the antibody is tailored in vitro (Winter et al., Ann. Rev. Immunol. 12 (1994), 433-455; Hoogenboom TIBTech Vol 15 (1997), 62-70). Gene segments which contain the coding sequence of the variable region of antibodies, ie the antigen binding site, are fused with genes for the coat protein of a bacteriophage. Then you infect bacterial with phages containing such fusion genes. The resulting phage particles now have envelopes with the antibody-like fusion protein, with the antibody-binding domain pointing outwards. The phage which contains the desired antibody fragment and specifically binds to a specific antigen can now be isolated from such a phage display library. Each phage isolated in this way produces a monoclonal, antigen-binding polypeptide which corresponds to a monoclonal antibody. The genes for the antigen binding site, which are unique for each phage, can be isolated from the phage DNA and used to construct complete antibody genes.
Auf dem Gebiet des Pflanzenschutzes wurden Antikörper insbesondere als analytisches Mittel ex-situ zum qualitativen und " quantitativen Nachweis von Antigenen genutzt. Dies schließt den Nachweis von Pflanzeninhaltstoffen, Herbiziden oder Fungiziden in Trinkwasser (Sharp et al. (1991) ACS Symp Ser. , 446 (Pestic. Re- sidues Food Saf . ) 87-95), Bodenproben (WO 9423018) oder in Pflanzen oder Pflanzenteilen sowie die Nutzung von AntikörpernIn the field of crop protection, antibodies have been used, in particular, as an analytical means ex situ for the qualitative and quantitative detection of antigens. This includes the detection of plant constituents, herbicides or fungicides in drinking water (Sharp et al. (1991) ACS Symp Ser., 446 (Pestic. Resides Food Saf.) 87-95), soil samples (WO 9423018) or in plants or parts of plants, and the use of antibodies
20 als Hilfsmittel zur Reinigung von gebundenen Molekülen ein.20 as an aid for the purification of bound molecules.
Die Produktion von Immunglobulinen in Pflanzen wurde erstmals von Hiatt et al., Nature, 342 (1989), 76 - 78 beschrieben. Das Spektrum reicht von Ein-Ketten-Antikörpern bis zu multimeren se¬The production of immunoglobulins in plants was first described by Hiatt et al., Nature, 342 (1989), 76-78. The spectrum ranges from single-chain antibodies to multimeric se¬
25 kretorischen Antikörpern (J. Ma und Mich Hein, 1996, Annuals New York Academy of Sciences, 72 - 81) .25 cretoric antibodies (J. Ma and Mich Hein, 1996, Annuals New York Academy of Sciences, 72-81).
Neuere Versuche nutzen Antikörper in-situ zur Pathogenabwehr in 30 Pflanzen, insbesondere von Viruserkrankungen durch Expression von spezifischen Antikörpern oder Teilen davon gerichtet gegen Virus - hüllproteine in Pflanzenzellen (Tavladoraki et al . , Nature 366 (1993), 469-472; Voss et al . , Mol. Breeding 1 (1995), 39-50).More recent experiments use antibodies in situ to ward off pathogens in 30 plants, in particular viral diseases by expression of specific antibodies or parts thereof directed against virus coat proteins in plant cells (Tavladoraki et al., Nature 366 (1993), 469-472; Voss et al ., Mol. Breeding 1 (1995), 39-50).
35 Ein analoger Ansatz ist auch zur Abwehr der Infektion der Pflanze durch Nematoden genutzt worden (Rosso et al., Biochem Biophys Res Com, 220 (1996) 255-263). Für eine pharmazeutische Anwendung sind Beispiele bekannt, die die Antikörper-Expression in-situ in Pflanzen für eine orale Immunisierung nutzen (Ma et al., Science35 An analogous approach has also been used to ward off the infection of the plant by nematodes (Rosso et al., Biochem Biophys Res Com, 220 (1996) 255-263). For a pharmaceutical application, examples are known which use antibody expression in-situ in plants for oral immunization (Ma et al., Science
40 268 (1995), 716-719; Mason und Arntzen, Tibtech Vol 13 (1996), 388-392) . Von der Pflanze gebildete Antikörper werden dabei aus Pflanzen oder für den Verzehr geeigneten Pflanzenteilen über den Mund, Rachen oder Verdauungstrakt dem Körper zugeführt und verursachen einen wirksamen Immunschutz. Weiterhin wurde in Pflanzen1995, 40: 268: 716-719; Mason and Arntzen, Tibtech Vol 13 (1996), 388-392). Antibodies formed by the plant are supplied to the body from plants or parts of plants suitable for consumption via the mouth, throat or digestive tract and cause effective immune protection. Furthermore, in plants
45 bereits ein Ein-Ketten-Antikörper (Single chain antibody) gegen das niedermolekulare Pflanzenhormon Abscisinsäure exprimiert und eine verringerte Pflanzenhormonverfügbarkeit aufgrund von Absei- sinsäurebindung in der Pflanze beobachtet (Artsaenko et al., The Plant Journal (1995) 8(5), 745-750).45 already expressed a single-chain antibody against the low-molecular plant hormone abscisic acid and reduced plant hormone availability due to abse- Acid binding in the plant was observed (Artsaenko et al., The Plant Journal (1995) 8 (5), 745-750).
Die chemische Pilzbekämpfung in agrarwirtschaftlich bedeutenden Kulturen setzt den Einsatz von hochselektiven Fungiziden ohne phytotoxische Wirkung voraus. Die phytotoxische Wirkung von Fungiziden kann beispielsweise auf einer Hemmung des Pflanzenwachstums, verminderter Photosyntheseleistung und damit verbundener verminderter Ertragsleistung beruhen. In einigen Fällen istThe chemical control of fungi in agronomically important crops requires the use of highly selective fungicides without phytotoxic effects. The phytotoxic effect of fungicides can, for example, be based on an inhibition of plant growth, reduced photosynthetic performance and the associated reduced yield. In some cases
*" es jedoch schwierig, Fungizide mit ausreichender Selektivität zu entwickeln, die in allen bedeutenden Pflanzengroßkulturen einsetzbar sind und in keiner Kultur eine Schädigung der Ertrags - pflanze verursachen. Die Einführung von Fungizid-resistenten oder -toleranten Kulturpflanzen kann zur Lösung dieses Problems bei- * "it difficult to develop fungicides with sufficient selectivity that can be used in all major vegetable wholesale cultures and no culture damage to the yield -. Plant cause The introduction of fungicide-resistant or tolerant crops can help to solve this problem in -
15 tragen und neue Verwendungsmöglichkei en von Fungiziden in bisher nicht oder nur unter Ertragsminderung behandelbaren Kulturen erschließen. 15 wear and develop new uses of fungicides in crops that were previously not treatable or could only be treated with reduced yield.
Der Entwicklung von Fungizid-resistenten Kulturpflanzen durch Ge0 webekultur oder Samenmutagenese und natürliche Auswahl sind Grenzen gesetzt. So muß einerseits die phytotoxische Wirkung bereits in Gerwebekultur erfaßbar sein und andererseits können nur diejenigen Pflanzen über Gewebekulturtechniken manipuliert werden, deren Regeneration zu ganzen Pflanzen aus Zellkulturen gelingt. 5 Außerdem können Kulturpflanzen nach Mutagenese und Selektion unerwünschte Eigenschaften zeigen, die durch teilweise mehrmalige Rückkreuzungen wieder beseitigt werden müssen. Auch wäre die Einbringung einer Resistenz durch Kreuzung auf Pflanzen der selben Art beschränkt. 0There are limits to the development of fungicide-resistant crops through tissue culture or seed mutagenesis and natural selection. On the one hand, the phytotoxic effect must be detectable in tissue culture and on the other hand, only those plants can be manipulated using tissue culture techniques whose regeneration to whole plants from cell cultures is successful. 5 In addition, after mutagenesis and selection, crop plants can show undesirable properties which have to be eliminated by repeated cross-breeding in some cases. The introduction of resistance by crossing to plants of the same species would also be restricted. 0
Aus diesen Gründen ist der gentechnische Ansatz, ein für die Resistenz codierendes Gen zu isolieren und in Kulturpflanzen gezielt zu übertragen, dem klassischen Züchtungsverfahren überle- 5 <?en.For these reasons, the genetic engineering approach of isolating a gene coding for resistance and transferring it specifically in crop plants is superior to the classic breeding method.
Die molekularbiologische Entwicklung von Herbizid-toleranten bzw. Herbizid-resistenten Kulturpflanzen setzt bisher voraus, daß der Wirkmechanismus des Herbizides in der Pflanze bekannt ist und daß 0 Gene, die Resistenz gegen das Herbizid vermitteln gefunden werden können. Viele gegenwärtig kommerziell genutzte Herbizide wirken, indem sie ein Enzym einer essentiellen Aminosäure-, Lipid- oder Pigmentbiosynthese blockieren. Durch Veränderung der Gene dieser Enzyme dergestalt, daß das Herbizid nicht mehr gebunden werden 5 kann und durch Einbringung dieser veränderten Gene in Kulturpflanzen läßt sich Herbizid-Toleranz erzeugen. Alternativ können zum Beispiel in der Natur analoge Enzyme beispielsweise in Mikro- Organismen gefunden werden, die eine natürliche Resistenz gegenüber dem Herbizid zeigen. Dieses Resistenz vermittelnde Gen wird aus einem derartigen Mikroorganismus isoliert, in geeignete Vektoren umkloniert und anschließend nach erfolgreicher Transforma- tion in Herbizid-sensitiven Kulturpflanzen zur Expression gebracht (WO 96/38567) .The molecular biological development of herbicide-tolerant or herbicide-resistant crop plants has hitherto presupposed that the mechanism of action of the herbicide in the plant is known and that 0 genes which impart resistance to the herbicide can be found. Many currently used herbicides work by blocking an enzyme of essential amino acid, lipid or pigment biosynthesis. By changing the genes of these enzymes such that the herbicide can no longer be bound and by introducing these changed genes into crop plants, herbicide tolerance can be generated. Alternatively, for example, enzymes analogous in nature can be found, for example, in micro- Organisms are found that show a natural resistance to the herbicide. This resistance-imparting gene is isolated from such a microorganism, cloned into suitable vectors and then, after successful transformation, expressed in herbicide-sensitive crop plants (WO 96/38567).
Aufgabe der vorliegenden Erfindung war die Entwicklung eines neuartigen allgemein einsetzbaren, gentechnologischen Verfahrens zur Erzeugung von Fungizid-toleranten transgenen Pflanzen.The object of the present invention was to develop a novel, generally applicable, genetic engineering method for producing fungicide-tolerant transgenic plants.
Diese Aufgabe wurde überraschenderweise gelöst durch ein Verfahren der Expression eines exogenen Polypeptides, Antikörpers oder Teilen eines Antikörpers mit Fungizid-bindenden Eigenschaften in den Pflanzen.This object was surprisingly achieved by a method of expressing an exogenous polypeptide, antibody or parts of an antibody with fungicide-binding properties in the plants.
Ein erster Gegenstand der vorliegenden Erfindung betrifft die Herstellung eines Fungizid-bindenden Antikörpers und die Klonierung des zugehörigen Gens bzw. Genfragmentes.A first object of the present invention relates to the production of a fungicide-binding antibody and the cloning of the associated gene or gene fragment.
Es wird zunächst ein geeigneter Antikörper erzeugt, der das Fungizid bindet. Dies kann u.a. durch Immunisierung eines Wirbeltiers, meist Maus, Ratte, Hund, Pferd, Esel oder Ziege mit einem Antigen erfolgen. Das Antigen ist dabei eine fungizid wirksame Verbindung, die über eine funktioneile Gruppe an einen höher - molekularen Träger wie Rinderserumalbumin (BSA) , Hühnereiweiß (Ovalbumin) , keyhole limpet hemocyanin (KLH) oder andere Träger gekoppelt oder assoziiert vorliegt. Die Immunantwort wird nach mehrmaliger Antigenapplikation mit gängigen Methoden nachvollzogen und so ein geeignetes Antiserum isoliert. Dieser Ansatz liefert zunächst ein polyklonales Serum, das Antikörper mit unterschiedlichen Spezifitäten enthält. Für den gezielten in-situ Gebrauch ist es notwendig, die für einen einzelnen spezifischen monoklonalen Antikörper codierende Gensequenz zu isolieren. Zu diesem Zweck stehen verschiedene Wege offen. Der erste Ansatz nutzt die Fusion von Antikörper-produzierenden Zellen mit Krebszellen zu einer ständig Antikörper produzierenden Hybridomazeil - kultur, die durch Vereinzelung der enthaltenen Klone letztlich zu einer homogenen, einen definierten monoklonalen Antikörper produzierenden Zellinie führt.A suitable antibody is first generated that binds the fungicide. This can include by immunizing a vertebrate, usually a mouse, rat, dog, horse, donkey or goat with an antigen. The antigen is a fungicidally active compound that is linked or associated via a functional group to a higher molecular carrier such as bovine serum albumin (BSA), chicken egg white (ovalbumin), keyhole limpet hemocyanin (KLH) or other carriers. After repeated application of antigen, the immune response is reproduced using common methods, thus isolating a suitable antiserum. This approach initially provides a polyclonal serum that contains antibodies with different specificities. For targeted in-situ use, it is necessary to isolate the gene sequence coding for a single specific monoclonal antibody. There are various ways of doing this. The first approach uses the fusion of antibody-producing cells with cancer cells to form a hybridoma cell culture that constantly produces antibodies, which, by separating the clones it contains, ultimately leads to a homogeneous cell line that produces a defined monoclonal antibody.
Aus einer derartigen monoklonalen Zellinie wird die cDNA für den Antikörper bzw. Teile des Antikörpers, den sog. Ein-Ketten-Anti- körper (single chain antibody - scFv) isoliert. Diese cDNA-Se- quenzen können dann in Expressionskassetten kloniert und zur funktionellen Expression in prokaryotischen und eukaryo ischen Organismen, einschließlich Pflanzen genutzt werden.The cDNA for the antibody or parts of the antibody, the so-called single chain antibody (scFv), is isolated from such a monoclonal cell line. These cDNA sequences can then be cloned in expression cassettes and for functional expression in prokaryotic and eukaryotic Organisms, including plants, can be used.
Es ist auch möglich über Phagen-Display-Banken Antikörper zu selektieren, die Fungizidmoleküle binden und katalytisch in ein Produkt mit nicht fungiziden Eigenschaften umsetzen. Methoden zur Herstellung katalytischer Antikörper sind in Janda et al., Science 275 (1997) 945-948, Chemical selection for catalysis in combinatorial Antibody libraries; Catalytic Antibodies, 1991, Ciba Foundation Symposium 159, Wiley- Interscience Publication beschrieben. Durch Klonierung des Gens dieses katalytischen Antikörpers und dessen Expression in einer Pflanze kann im Prinzip ebenfalls eine Fungizid-resistente Pflanze erzeugt werden.It is also possible to use phage display banks to select antibodies that bind fungicide molecules and catalytically convert them into a product with non-fungicidal properties. Methods for producing catalytic antibodies are described in Janda et al., Science 275 (1997) 945-948, Chemical selection for catalysis in combinatorial Antibody libraries; Catalytic Antibodies, 1991, Ciba Foundation Symposium 159, Wiley-Interscience Publication. In principle, a fungicide-resistant plant can also be produced by cloning the gene of this catalytic antibody and expressing it in a plant.
Gegenstand der Erfindung sind insbesondere Expressionskassetten, deren kodierende Sequenz für ein Fungizid-bindendes Polypeptid oder dessen funktionelles Äquivalent codiert, sowie deren Verwendung zur Herstellung einer Fungizid-toleranten Pflanze. Die Nukleinsäuresequenz kann dabei z.B. eine DNA- oder eine cDNA-Se- quenz sein. Zur Insertion in eine erfindungsgemäße Expressions - kassette geeignete kodierende Sequenzen sind beispielsweise solche, die eine DNA-Sequenz aus einer Hybridomazelle enthalten, die für ein Polypeptid mit Fungizid-bindenden Eigenschaften codiert und die somit dem Wirt Resistenz gegen bestimmte Fungizide verleihen.The invention particularly relates to expression cassettes, the coding sequence of which codes for a fungicide-binding polypeptide or its functional equivalent, and their use for producing a fungicide-tolerant plant. The nucleic acid sequence can e.g. be a DNA or a cDNA sequence. Coding sequences suitable for insertion into an expression cassette according to the invention are, for example, those which contain a DNA sequence from a hybridoma cell which codes for a polypeptide with fungicide-binding properties and which thus give the host resistance to certain fungicides.
Die erfindungsgemäßen Expressionskassetten beinhalten außerdem regulative Nukleinsäuresequenzen, welche die Expression der codierenden Sequenz in der Wirtszelle steuern. Gemäß einer bevor - zugten Ausführungsform umfaßt eine erfindungsgemäße Expressions - kassette stromaufwärts, d.h. am 5 '-Ende der codierenden Sequenz einen Promotor und stromabwärts, d.h. am 3 ' -Ende ein Polyadeny- lierungssignal und gegebenenfalls weitere regulatorische Elemente, welche mit der dazwischenliegenden codierenden Sequenz für das Polypeptid mit Fungizid-bindenden Eigenschaften und/oder Transitpeptid operativ verknüpft sind. Unter einer operativen Verknüpfung versteht man die sequenzielle Anordnung von Promotor, codierender Sequenz, Terminator und ggf. weiterer regulativer Elemente derart, daß jedes der regulativen Elemente seine Funk- tion bei der Expression der codierenden Sequenz bestimmungsgemäß erfüllen kann. Die zur operativen Verknüpfung bevorzugten aber nicht darauf beschränkten Sequenzen sind Targeting-Sequenzen zur Gewährleistung der subzellulären Lokalisation im Apoplasten, in der Plasmamembran, in der Vakuole, in Piastiden, ins Mitochon- drium, im Endoplasmatischen Retikulum (ER), im Zellkern, in Öl - körperchen oder anderen Kompartimenten und Translationsverstärker wie die 5' -Führungssequenz aus dem Tabak Mosaic Virus (Gallie et
Figure imgf000009_0001
The expression cassettes according to the invention also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell. According to a preferred embodiment, an expression cassette according to the invention comprises a promoter upstream, ie at the 5 'end of the coding sequence, and downstream, ie at the 3' end, a polyadenylation signal and, if appropriate, further regulatory elements which are associated with the coding sequence in between are operatively linked to the polypeptide with fungicide-binding properties and / or transit peptide. An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence. The sequences preferred but not limited to the operative linkage are targeting sequences to ensure subcellular localization in the apoplast, in the plasma membrane, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil - corpuscles or other compartments and translation enhancers such as the 5 'leadership sequence from the tobacco mosaic virus (Gallie et
Figure imgf000009_0001
Figure imgf000009_0002
Figure imgf000009_0002
beispielhaft dargestellt.shown as an example.
Die Herstellung einer erfindungsgemäßen Expressionskassette erfolgt durch Fusion eines geeigneten Promotors mit einer geeigne- ten Polypeptid-DNA und vorzugsweise einer zwischen Promotor und Polypeptid-DNA insertierten für ein Chloroplasten-spezifisches Transitpeptid kodierenden DNA sowie einem Polyadenylierungssignal nach gängigen Rekombinations- und Klonierungstechniken, wie sie beispielsweise in T. Maniatis, E.F. Fritsch und J. Sambrook, Mo- lecular Cloning: A Laboratory manual, Cold Spring Harbor Labora- tory, Cold Spring Harbor, NY (1989) sowie in T.J. Silhavy, M.L. Berman und L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) und in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987) beschrieben sind.An expression cassette according to the invention is produced by fusing a suitable promoter with a suitable polypeptide DNA and preferably a DNA coding for a chloroplast-specific transit peptide and a polyadenylation signal inserted between the promoter and polypeptide DNA and a polyadenylation signal according to common recombination and cloning techniques, such as, for example in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
Insbesondere bevorzugt sind Sequenzen, die ein Targeting in den Apoplasten, Piastiden, die Vakuole, in die Plasmamembran, das Mitochondrium, das Endoplasmatische Retikulum (ER) oder durch ein Fehlen entsprechender operativer Sequenzen einen Verbleib im Kompartiment des Entstehens, dem Zytosol, gewährleisten (Kermode, Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Für die Menge der Proteinakkumulation in transgenen Pflanzen besonders förderlich erwiesen hat sich eine Lokalisation im ER sowie der Zellwand (Schouten et al. , Plant Mol. Biol . 30 (1996), 781-792; Artsaenko et al., Plant J. 8 (1995) 745-750).Particularly preferred are sequences which ensure targeting in the apoplasts, plastids, the vacuole, in the plasma membrane, the mitochondrium, the endoplasmic reticulum (ER) or by a lack of corresponding operative sequences, ensuring that they remain in the compartment of formation, the cytosol (Kermode , Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Localization in the ER and in the cell wall has proven to be particularly beneficial for the amount of protein accumulation in transgenic plants (Schouten et al., Plant Mol. Biol. 30 (1996), 781-792; Artsaenko et al., Plant J. 8 ( 1995) 745-750).
Gegenstand der Erfindung sind auch Expressionskassetten, deren kodierende Sequenz für ein Fungizid-bindendes Fusionsprotein kodiert, wobei Teil des Fusionsproteins ein Transitpeptid ist, das die Translokation des Polypeptides steuert. Besonders bevorzugt sind Chloroplasten-spezifische Transitpeptide, welche nach Trans - lokation des Fungizid-bindenden Polypeptides in die Pflanzench- loroplasten vom Fungizid-bindenden Polypeptid-Teil enzymatisch abgespalten werden. Insbesondere bevorzugt ist das Transitpeptid abgeleitet von plastidärer Transketolase (TK) oder einem funktio- nellen Äquivalent dieses Transitpeptids (z.B. das Transitpeptid der kleinen Untereinheit der Rubisco oder der Ferredoxin NADP Oxidoreduktase) .The invention also relates to expression cassettes, the coding sequence of which codes for a fungicide-binding fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide. Chloroplast-specific transit peptides which are split off enzymatically from the fungicide-binding polypeptide part after transposition of the fungicide-binding polypeptide into the plant chloroplasts are particularly preferred. The transit peptide is particularly preferably derived from plastidic transketolase (TK) or a functional equivalent of this transit peptide (e.g. the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase).
Die zur Herstellung erfindungsgemäßer Expressionskassetten erforderliche Polypeptid-DNA oder -cDNA wird vorzugsweise mit Hilfe der Polymerase-Kettenreaktion (PCR) amplifiziert. Verfahren zur DNA-Amplifikation mittels PCR sind bekannt, beispielsweise aus Innis et al., PCR Protocols, A Guide to Methods and Applications, Academic Press (1990) . Zweckmäßigerweise können die PCR-erzeugten DNA-Fragmente durch Sequenzanalyse zur Vermeidung von Polymerase- fehlern in zu exprimierenden Konstrukten überprüft werden.The polypeptide DNA or cDNA required for the production of expression cassettes according to the invention is preferably amplified with the aid of the polymerase chain reaction (PCR). Methods for DNA amplification by means of PCR are known, for example from Innis et al., PCR Protocols, A Guide to Methods and Applications, Academic Press (1990). The PCR-generated DNA fragments can expediently be checked by sequence analysis to avoid polymerase errors in constructs to be expressed.
5 Die insertierte Nucleotid-Sequenz codierend für ein Fungizid-bindendes Polypeptid kann synthetisch hergestellt oder natürlich gewonnen sein oder eine Mischung aus synthetischen und natürlichen DNA-Bestandteilen enthalten. Im allgemeinen werden synthetische Nucleotid-Sequenzen mit Codons erzeugt, die von Pflanzen bevor¬ 5 The inserted nucleotide sequence coding for a fungicide-binding polypeptide can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components. In general, synthetic nucleotide sequences with codons are generated which are preferred by plants
10 zugt werden. Diese von Pflanzen bevorzugten Codons können aus Codons mit der höchsten Proteinhäufigkeit bestimmt werden, die in den meisten interessanten Pflanzenspezies exprimiert werden. Bei der Präparation einer Expressionskassette können verschiedene DNA-Fragmente manipuliert werden, um eine Nucleotid-Sequenz zu -'-' erhalten, die zweckmäßigerweise in der korrekten Richtung liest und die mit einem korrekten Leseraster ausgestattet ist. Für die Verbindung der DNA-Fragmente miteinander können an die Fragmente Adaptoren oder Linker angesetzt werden.10 are added. These plant preferred codons can be determined from the highest protein frequency codons expressed in most interesting plant species. When preparing an expression cassette, various DNA fragments can be manipulated to a nucleotide sequence to - '■ -' obtained which expediently reads in the correct direction and is equipped with a correct reading frame. To connect the DNA fragments to one another, adapters or linkers can be attached to the fragments.
2020th
Zweckmäßigerweise sollten die erfindungsgemäßen Promotor- und die Terminator-Regionen in Transkriptionsrichtung mit einem Linker oder Polylinker, der eine oder mehrere Restriktionsstellen für die Insertion dieser Sequenz enthält, versehen werden. In der Regel hat der Linker 1 bis 10, meistens 1 bis 8, vorzugsweise 2 5 bis 6 Restriktionsstellen. Im allgemeinen hat der Linker innerhalb der regulatorischen Bereiche eine Größe von weniger als 100 bp, häufig weniger als 60 bp, mindestens jedoch 5 bp. Der erfindungsgemäße Promotor kann sowohl nativ bzw. homolog als auch fremdartig bzw. heterolog zur Wirtspflanze sein. Die erfindungs0 gemäße Expressionskassette beinhaltet in der 5 ' -3' -Transkripti - onsrichtung den erfindungsgemäßen Promotor, eine beliebige Sequenz und eine Region für die transkriptionale Termination. Verschiedene Terminationsbereiche sind gegeneinander beliebig austauschbar. 5The promoter and terminator regions according to the invention should expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence. As a rule, the linker has 1 to 10, usually 1 to 8, preferably 2 5 to 6 restriction sites. In general, the linker has a size of less than 100 bp, often less than 60 bp, but at least 5 bp within the regulatory ranges. The promoter according to the invention can be both native or homologous and foreign or heterologous to the host plant. The expression cassette according to the invention contains, in the 5 '-3' transcription direction, the promoter according to the invention, any sequence and a region for the transcriptional termination. Different termination areas are interchangeable. 5
Ferner können Manipulationen, die passende Restriktionsschnittstellen bereitstellen oder die überflüssige DNA oder Restriktionsschnittstellen entfernen, eingesetzt werden. Wo Insertionen, 0 Deletionen oder Substitutionen wie z.B. Transitionen und Trans - Versionen in Frage kommen, können in vitro-Mutagenese, "primerre- pair", Restriktion oder Ligation verwendet werden. Bei geeigneten Manipulationen, wie z.B. Restriktion, "chewing-back" oder Auffüllen von Überhängen für "bluntends", können komplementäre Enden 5 der Fragmente für die Ligation zur Verfügung gestellt werden. ^ SH ^ ΦManipulations which provide suitable restriction sites or which remove superfluous DNA or restriction sites can also be used. Where insertions, deletions or substitutions such as transitions and trans versions are possible, in vitro mutagenesis, "primer pair", restriction or ligation can be used. With suitable manipulations, such as restriction, "chewing-back" or filling in overhangs for "blunt ends", complementary ends 5 of the fragments can be provided for the ligation. ^ SH ^ Φ
Figure imgf000012_0001
Figure imgf000012_0001
Zur Transformation einer Wirtspflanze mit einer für ein Fungizidbindendes Polypeptid codierenden DNA wird eine erfindungsgemäße Expressionskassette als Insertion in einen rekombinanten Vektor eingebaut, dessen Vektor-DNA zusätzliche funktionelle Regulati- onssignale, beispielsweise Sequenzen für Replikation oder Integration enthält. Geeignete Vektoren sind unter anderem in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Kap. 6/7, S.71-119 (1993) beschrieben.To transform a host plant with a DNA coding for a fungicide-binding polypeptide, an expression cassette according to the invention is inserted as an insert in a recombinant vector, the vector DNA of which contains additional functional regulatory signals, for example sequences for replication or integration. Suitable vectors are inter alia in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, p.71-119 (1993).
Unter Verwendung der oben zitierten Rekombinations- undUsing the recombination and
Klonierungstechniken können die erfindungsgemäßen Expressionskassetten in geeignete Vektoren kloniert werden, die ihre Vermehrung, beispielsweise in E. coli, ermöglichen. Geeignete Klonie- rungsvektoren sind u.a. pBR332, pUC-Serien, M13mp-Serien und pA- CYC184. Besonders geeignet sind binäre Vektoren, die sowohl in E. coli als auch in Agrobakterien replizieren können, wie z.B. pBinl9 (Bevan et al . (1980) Nucl . Acids Res. 12, 8711).Cloning techniques can be cloned the expression cassettes according to the invention into suitable vectors that allow their multiplication, for example in E. coli. Suitable cloning vectors include pBR332, pUC series, M13mp series and pA-CYC184. Binary vectors which can replicate both in E. coli and in agrobacteria, such as e.g. pBin19 (Bevan et al. (1980) Nucl. Acids Res. 12, 8711).
Ein weiterer Gegenstand der Erfindung betrifft die Verwendung einer erfindungsgemäßen Expressionskassette zur Transformation von Pflanzen, Pflanzenzellen, -geweben oder Pflanzenteilen. Vorzugsweise ist Ziel der Verwendung die Vermittlung von Resistenz gegen Fungizide mit phytotoxischer Wirkung.Another object of the invention relates to the use of an expression cassette according to the invention for the transformation of plants, plant cells, plant tissues or parts of plants. The aim of the use is preferably to impart resistance to fungicides with phytotoxic activity.
Dabei kann je nach Wahl des Promotors die Expression spezifisch in den Blättern, in den Samen oder anderen Teilen der Pflanze erfolgen. Solche transgenen Pflanzen, deren Vermehrungsgut sowie deren Pflanzenzellen, -gewebe oder -teile sind ein weiterer Ge- genstand der vorliegenden Erfindung.Depending on the choice of the promoter, the expression can take place specifically in the leaves, in the seeds or in other parts of the plant. Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further object of the present invention.
Die Übertragung von Fremdgenen in das Genom einer Pflanze wird als Transformation bezeichnet. Es werden dabei die beschriebenen Methoden zur Transformation und Regeneration von Pflanzen aus Pflanzengeweben oder Pflanzenzellen zur transienten oder stabilen Transformation genutzt. Geeignete Methoden sind die Protoplasten- transformation durch Polyethylenglykol-induzierte DNA-Aufnahme, der biolistische Ansatz mit der Genkanone, die Elektroporation, die Inkubation trockener Embryonen in DNA-haltiger Lösung, die Mikroinjektion und der Agrobacterium-vermittelte Gentransfer. Die genannten Verfahren sind beispielsweise in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, herausgegeben von S.D. Kung und R. Wu, Academic Press (1993) 128-143 sowie in Potrykus Annu.Rev. Plant Physiol. Plant Molec.Biol. 42 (1991) 205-225) beschrieben. Vorzugsweise wird das zu exprimierende Konstrukt in einen Vektor kloniert, der geeignet ist, Agrobacterium tumefaciens zu trans- formieren, beispielsweise pBinl9 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).The transfer of foreign genes into the genome of a plant is called transformation. The methods described for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic approach with the gene cannon, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and Agrobacterium-mediated gene transfer. The methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu.Rev. Plant Physiol. Plant Molec.Biol. 42 (1991) 205-225). The construct to be expressed is preferably cloned into a vector which is suitable for transcribing Agrobacterium tumefaciens form, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).
Mit einer erfindungsgemäßen Expressionskassette transformierte Agrobakterien können dann in bekannter Weise zur Transformation von Pflanzen, insbesondere von Kulturpflanzen, wie Getreide, Mais, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Kartoffel, Tabak, Tomate, Raps, Alfalfa, Salat und den verschiedenen Busch-, Baum-, Nuß- und Weinspezies, wie beispiels- weise Kaffee, Obstbäume wie Apfel, Birnen oder Kirschen, Nußbäume wie Walnuß oder Pecan und besonders wichtig in Reben verwendet werden, z.B. indem verwundete Blätter oder Blattstücke in einer Agrobakterienlosung gebadet und anschließend in geeigneten Medien kultiviert werden.Agrobacteria transformed with an expression cassette according to the invention can then be used in a known manner to transform plants, in particular crop plants, such as cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various bush, tree, nut and wine species, such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly importantly used in vines, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
Funktioneil äquivalente Sequenzen, die ein Fungizid-bindendes Polypeptid codieren, sind erfindungsgemäß solche Sequenzen, welche trotz abweichender Nucleotidsequenz noch die gewünschten Funktionen besitzen. Funktionelle Äquivalente umfassen somit natürlich vorkommende Varianten der hierin beschriebenen Sequenzen sowie künstliche, z.B. durch chemische Synthese erhaltene, an die Codon-Usage einer Pflanze angepaßte, künstliche Nucleotid-Sequen- zen.Functionally equivalent sequences which encode a fungicide-binding polypeptide are, according to the invention, those sequences which, despite a different nucleotide sequence, still have the desired functions. Functional equivalents thus include naturally occurring variants of the sequences described herein as well as artificial, e.g. Artificial nucleotide sequences obtained by chemical synthesis and adapted to the codon usage of a plant.
Unter einem funktioneilen Äquivalent versteht man insbesondere auch natürliche oder künstliche Mutationen einer ursprünglich isolierten das Fungizid-bindende Polypeptid codierenden Sequenz, welche weiterhin die gewünschte Funktion zeigen. Mutationen um- fassen Substitutionen, Additionen, Deletionen, Vertauschungen oder Insertionen eines oder mehrerer Nukleotidreste. Somit werden beispielsweise auch solche Nucleotidsequenzen durch die vorliegende Erfindung mit umfaßt, welche man durch Modifikation dieser Nucleotidsequenz erhält. Ziel einer solchen Modifikation kann z.B. die weitere Eingrenzung der darin enthaltenen codierenden Sequenz oder z.B. auch die Einfügung weiterer Restriktionsenzym- Schnittstellen sein.A functional equivalent is understood to mean, in particular, natural or artificial mutations of an originally isolated sequence encoding the fungicide-binding polypeptide, which furthermore show the desired function. Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues. Thus, for example, the present invention also encompasses those nucleotide sequences which are obtained by modification of this nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also the insertion of further restriction enzyme interfaces.
Funktionelle Äquivalente sind auch solche Varianten, deren Funk- tion, verglichen mit dem Ausgangsgen bzw. Genfragment, abgeschwächt oder verstärkt ist.Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
Außerdem sind artifizielle DNA-Sequenzen geeignet, solange sie, wie oben beschrieben, die gewünschte Toleranz gegenüber Fungiziden zur Vermeidung phytotoxischer Effekte an Kulturpflanzen vermitteln. Solche artifiziellen DNA-Sequenzen können beispielsweise durch Rückübersetzung mittels Molecular Modelling konstruierter Proteine, die Fungizid-bindende Aktivität aufweisen oder durch in vitro-Selektion ermittelt werden. Besonders geeignet sind kodierende DNA-Sequenzen, die durch Rückübersetzung einer Polypeptid- sequenz gemäß der für die Wirtspflanze spezifischen Codon-Nutzung 5 erhalten wurden. Die spezifische Codon-Nutzung kann ein mit pflanzengenetischen Methoden vertrauter Fachmann durch Computerauswertungen anderer, bekannter Gene der zu transformierenden Pflanze leicht ermitteln.In addition, artificial DNA sequences are suitable as long as, as described above, they impart the desired tolerance to fungicides to avoid phytotoxic effects on crop plants. Such artificial DNA sequences can be constructed, for example, by back-translation using molecular modeling Proteins that have fungicide-binding activity or are determined by in vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence in accordance with the codon usage 5 specific for the host plant are particularly suitable. The specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
_ Als weitere erfindungsgemäße geeignete äquivalente Nukleinsäure-_ As further suitable equivalent nucleic acid
Sequenzen sind zu nennen Sequenzen, welche für Fusionsproteine kodieren, wobei Bestandteil des Fusionsproteins ein nicht-pflanzliches Fungizid-bindendes Polypeptid oder ein funktioneil äquivalenter Teil davon ist. Der zweite Teil des Fusionsproteins kann 5 z.B. ein weiteres Polypeptid mit enzymatischer Aktivität sein oder eine antigene Polypeptidsequenz mit deren Hilfe ein Nachweis auf scFvs Expression möglich ist (z.B. myc-tag oder his-tag) . Bevorzugt handelt es sich dabei jedoch um eine regulative Proteinsequenz, wie z.B. ein Signal- oder Transitpeptid, das das 0 Polypeptid mit Fungizid-bindenden Eigenschaften an den gewünschten Wirkort leitet.Sequences are to be called sequences which code for fusion proteins, part of the fusion protein being a non-vegetable fungicide-binding polypeptide or a functionally equivalent part thereof. The second part of the fusion protein may be 5, for example, another polypeptide having enzymatic activity or be an antigenic polypeptide sequence by means of which detection of scFvs expression is possible (for example myc-tag or his-tag). However, this is preferably a regulatory protein sequence, such as a signal or transit peptide, which directs the polypeptide with fungicide-binding properties to the desired site of action.
Gegenstand der Erfindung sind aber auch die erfindungsgemäß erzeugten Expressionsprodukte, sowie Fusionsproteine aus einem 5 Transitpeptid und einem Polypeptid mit Fungizid-bindenden Eigenschaften.The invention also relates to the expression products produced according to the invention and to fusion proteins composed of a transit peptide and a polypeptide with fungicide-binding properties.
Resistenz bzw. Toleranz bedeutet im Rahmen der vorliegenden Er- 0 findung die künstlich erworbene Widerstandsfähigkeit von Pflanzen gegenüber Fungiziden mit phytotoxischer Wirkung. Sie umfaßt die partielle und, insbesondere, die vollständige Unempfindlichkeit gegenüber diesen Inhibitoren für die Dauer mindestens einer Pflanzengeneration. 5Resistance or tolerance in the context of the present invention means the artificially acquired resistance of plants to fungicides with phytotoxic activity. It includes the partial and, in particular, the complete insensitivity to these inhibitors for at least one generation of plants. 5
Der phytotoxische Wirkort von Fungiziden ist im allgemeinen das Blattgewebe, so daß eine blattspezifische Expression des exogenen Fungizid-bindenden Polypeptides ausreichenden Schutz bieten kann. Es ist jedoch naheliegend, daß die phytotoxische Wirkung eines 0 Fungizids nicht auf das Blattgewebe beschränkt sein muß, sondern auch in allen übrigen Teilen der Pflanze gewebespezifisch erfolgen kann.The phytotoxic site of action of fungicides is generally the leaf tissue, so that leaf-specific expression of the exogenous fungicide-binding polypeptide can offer adequate protection. However, it is obvious that the phytotoxic effect of a fungicide need not be restricted to the leaf tissue, but can also be tissue-specific in all other parts of the plant.
Darüberhinaus ist eine konstitutive Expression des exogenen Fun- ^ gizid-bindenden Polypeptides von Vorteil. Andererseits kann aber auch eine induzierbare Expression wünschenswert erscheinen. Die Wirksamkeit des transgen exprimierten Polypeptides mit Fungizid-bindenden Eigenschaften kann beispielsweise in vitro durch Sproßmeristemvermehrung auf Fungizid-haltigem Medium über abgestufte Konzentrationsreihen oder über Samenkeimungstests ermit- 5 telt werden. Zudem kann eine in Art und Höhe veränderte Fungizid- Verträglichkeit einer Testpflanze in Gewächshausversuchen getestet werden.In addition, constitutive expression of the exogenous fungicide-binding polypeptide is advantageous. On the other hand, inducible expression may also appear desirable. The efficacy of the transgenically expressed polypeptide with fungicide-binding properties can be determined, for example, in vitro by increasing the number of shoots on fungicide-containing medium using graduated series of concentrations or using seed germination tests. In addition, a fungicide tolerance of a test plant which has been modified in terms of type and amount can be tested in greenhouse experiments.
Gegenstand der Erfindung sind außerdem transgene Pflanzen, trans- υ formiert mit einer erfindungsgemäßen Expressionskassette, sowie transgene Zellen, Gewebe, Teile und Vermehrungsgut solcher Pflanzen. Besonders bevorzugt sind dabei transgene Kulturpflanzen, wie z.B. Getreide, Mais, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Kartoffel, Tabak, Tomate, Raps, Alfalfa, Sa- 3 lat und die verschiedenen Busch-, Baum-, Nuß- und Weinspecies wie beispielsweise Kaffee, Obstbäume wie Apfel, Birnen oder Kirschen, Nußbäume wie Walnuß oder Pecan und besonders wichtig die Rebe.The invention furthermore relates to transgenic plants, trans- υ formed with an inventive expression cassette, as well as transgenic cells, tissue, parts and propagation material of such plants. Transgenic crop plants, such as, for example, cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, Sa 3 lat and the various bush, tree, Nut and wine species such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly important the vine.
Die transgenen Pflanzen, Pflanzenzellen, -gewebe oder -teile kön0 nen mit einem Fungizid mit phytotoxischer Wirkung, das die pflanzlichen Enzyme inhibiert, behandelt werden, wodurch die nicht erfolgreich transformierten Pflanzen, -zellen, -gewebe oder Pflanzenteile absterben bzw. geschädigt werden. Beispiele für geeignete Wirkstoffe sind Strobilurine insbesondere 5 Methyl methoxyimino-α- (o-tolyloxy) -o-tolylacetate ( BAS 490F ), sowie Metabolite und funktioneile Derivate dieser Verbindungen. Die in die erfindungsgemäßen Expressionskassetten insertierte, für ein Polypeptid mit Fungizid-bindenden Eigenschaften codierende DNA, kann somit auch als Selektionsmarker verwendet werden. 0The transgenic plants, plant cells, tissue or parts can be treated with a fungicide with a phytotoxic effect which inhibits the plant enzymes, as a result of which the plants, cells, tissue or plant parts which have not been successfully transformed die or are damaged. Examples of suitable active ingredients are strobilurins, in particular 5 methyl methoxyimino-α- (o-tolyloxy) -o-tolylacetate (BAS 490F), and metabolites and functional derivatives of these compounds. The DNA inserted into the expression cassettes according to the invention and coding for a polypeptide with fungicide-binding properties can thus also be used as a selection marker. 0
Insbesondere bei Kulturpflanzen bietet die vorliegende Erfindung den Vorteil, daß nach Induktion einer selektiven Resistenz der Kulturpflanze gegenüber Fungiziden mit phytotoxischer Wirkung 5 derartige Fungizide in diesen Kulturen auch mit höheren Aufwandmengen zur Bekämpfung von Schadpilzen eingesetzt werden können, die sonst zu Pflanzenschäden führen würden. Als nicht-limitie- rende Beispiele für derartige Fungizide mit phytotoxischer Wirkung können Verbindungen aus den folgenden Gruppen genannt wer- o den:In particular in the case of crop plants, the present invention offers the advantage that, after induction of a selective resistance of the crop plant to fungicides having a phytotoxic effect, 5 such fungicides can also be used in these crops at higher application rates to control harmful fungi which would otherwise lead to plant damage. Compounds from the following groups can be mentioned as non-limiting examples of such fungicides with phytotoxic activity:
• Schwefel, Dithiocarbamate und deren Derivate, wie Ferridime- thyldithiocarbamat, Zinkdimethyldithiocarbamat, Zinkethylenbis- dithiocarbamat, Manganethylenbisdithiocarbamat, Mangan-Zink- ethylendiamin-bis-dithiocarbamat, Tetramethylthiuramdisulfide, Ammoniak-Komplex von Zink- (N,N-ethylen-bis-dithiocarbamat) , Ammoniak-Komplex von Zink- (N,N' -propylen-bis-dithiocarbamat) , Zink- (N,N' -propylenbis-dithiocarbamat) , N,N' -Polypropylen- bis- (thiocarbamoyl) disulfid;Sulfur, dithiocarbamates and their derivatives, such as ferridimethyldithiocarbamate, zinc dimethyldithiocarbamate, zinc ethylene bisdithiocarbamate, manganese ethylene bisdithiocarbamate, manganese zinc ethylenediamine bisdithiocarbamate, tetramethylthiammonodiaminodisulfate , Ammonia complex of zinc (N, N '-propylene-bis-dithiocarbamate), Zinc (N, N '-propylenebis-dithiocarbamate), N, N' -polypropylene-bis- (thiocarbamoyl) disulfide;
• Nitroderivate, wie Dinitro- (1-methylheptyl) -phenylcrotonat, 2-sec-Butyl-4, 6-dinitrophenyl-3, 3-dimethylacrylat, 2-sec-Bu- tyl-4, 6-dinitrophenyl-isopropylcarbonat, 5-Nitro-isoph- thalsäure-di-isopropylester;Nitroderivate, such as dinitro- (1-methylheptyl) phenylcrotonate, 2-sec-butyl-4, 6-dinitrophenyl-3, 3-dimethylacrylate, 2-sec-butyl-4, 6-dinitrophenyl-isopropyl carbonate, 5- Di-isopropyl nitro-isophthalate;
• heterocyclische Substanzen, wie 2-Heptadecyl-2-imidazolin-ace- tat, 2 , 4-Dichlor-6- (o-chloranilino) -s-triazin, 0,0-Diethyl- phthalimidophosphonothioat, 5-Amino-l- [bis- (dimethylamino) - phosphinyl] -3-phenyl-l, 2, 4- triazol, 2 , 3-Dicyano-l, -dithioan- thrachinon, 2-Thio-l, 3-dithiolo [4, 5-b] chinoxalin, l-(Butylcar- bamoyl) -2-benzimidazol-carbaminsäuremethylester, 2-Methoxycar- bonylamino-benzimidazol, 2- (Furyl- (2) ) -benzimidazol, 2-(Thiazo- lyl- (4) ) -benzimidazol, N- (1, 1, 2, 2-Tetrachlorethylthio) -tetrahy- drophthalimid, N-Trichlormethylthio-tetrahydrophthalimid,Heterocyclic substances, such as 2-heptadecyl-2-imidazoline acetate, 2,4-dichloro-6- (o-chloroanilino) -s-triazine, 0.0-diethyl-phthalimidophosphonothioate, 5-amino-l- [ bis- (dimethylamino) - phosphinyl] -3-phenyl-l, 2, 4-triazole, 2, 3-dicyano-l, -dithioanthraquinone, 2-thio-l, 3-dithiolo [4, 5-b] quinoxaline, l- (butylcarbamoyl) -2-benzimidazole-carbamic acid methyl ester, 2-methoxycarbonylamino-benzimidazole, 2- (furyl- (2)) -benzimidazole, 2- (thiazolyl- (4)) -benzimidazole, N- (1, 1, 2, 2-tetrachloroethylthio) tetrahydrophthalimide, N-trichloromethylthio-tetrahydrophthalimide,
N-Trichlormethylthio-phthalimid,N-trichloromethylthio-phthalimide,
• N-Dichlorfluormethylthio-N' ,N' -dimethyl-N-phenyl-schwefelsäure- diamid, 5-Ethoxy-3-trichlormethyl-l, 2, 3-thiadiazol, 2-Rhodanme- thylthiobenzthiazol, 1, 4-Dichlor-2 , 5-dimethoxybenzol,• N-dichlorofluoromethylthio-N ', N' -dimethyl-N-phenylsulfuric acid diamide, 5-ethoxy-3-trichloromethyl-1,2,3-thiadiazole, 2-rhodanomethylthiobenzothiazole, 1,4-dichloro-2 , 5-dimethoxybenzene,
4- (2-Chlorphenylhydrazono) -3-methyl-5-isoxazolon, Pyridin-2- thio-1-oxid, 8-Hydroxychinolin bzw. dessen Kupfersalz, 2,3-Di- hydro-5-carboxanilido-6-methyl-l, 4-oxathiin, 2, 3-Dihydro-5-car- boxanilido-6-methyl-l, -oxathiin-4 , 4-dioxid, 2-Methyl-5, 6-dihy- dro-4H-pyran-3-carbonsäure-anilid, 2-Methyl-furan-3-carbonsäu- reanilid, 2, 5-Dimethyl-furan-3-carbonsäureanilid, 2,4,5-Trime- thyl-furan-3-carbonsäureanilid, 2, 5-Dimethyl-furan-3-carbonsäu- recyclohexylamid, N-Cyclohexyl-N-methoxy-2, 5-dimethyl-fu- ran-3-carbonsäureamid, 2-Methyl-benzoesäure-anilid, 2-Iod-ben- zoesäure-anilid, N-Formyl-N-morpholin-2 , 2, 2-trichlorethylace- tal, Piperazin-1, 4-diylbis-l- (2,2, 2-trichlorethyl) -formamid, 1- (3 , 4-Dichloranilino) -1-formylamino-2 , 2 , 2-trichlorethan,4- (2-chlorophenylhydrazono) -3-methyl-5-isoxazolone, pyridine-2-thio-1-oxide, 8-hydroxyquinoline or its copper salt, 2,3-di-hydro-5-carboxanilido-6-methyl- l, 4-oxathiin, 2, 3-dihydro-5-car-boxanilido-6-methyl-l, -oxathiin-4, 4-dioxide, 2-methyl-5, 6-dihydro-4H-pyran-3 -carboxylic acid anilide, 2-methyl-furan-3-carboxylic acid anilide, 2, 5-dimethyl-furan-3-carboxylic acid anilide, 2,4,5-trimethyl-furan-3-carboxylic acid anilide, 2, 5-dimethyl -furan-3-carboxylic acid- recyclohexylamide, N-cyclohexyl-N-methoxy-2, 5-dimethyl-furan-3-carboxamide, 2-methyl-benzoic acid anilide, 2-iodo-benzoic acid anilide, N -Formyl-N-morpholine-2,2,2-trichloroethyl-talc, piperazin-1,4-diylbis-l- (2,2,2-trichloroethyl) -formamide, 1- (3,4-dichloroanilino) -1 -formylamino-2,2,2-trichloroethane,
• Amine wie 2, 6-Dimethyl-N-tridecyl-morpholin bzw. dessen Salze, 2, 6-Dimethyl-N-cyclododecyl-morpholin bzw. dessen Salze, N- [3- (p-tert.-Butylphenyl) -2-methylpropyl] -cis-2, 6-dimethyl- morpholin, N- [3- (p-tert . -Butylphenyl) -2-methylpropyl] -piperi- din, (8- (1, 1-Dimethylethyl) -N-ethyl-N-propyl-1, 4-dioxas- piro [4.5] decan-2-methanamin,• Amines such as 2, 6-dimethyl-N-tridecyl-morpholine or its salts, 2, 6-dimethyl-N-cyclododecyl-morpholine or its salts, N- [3- (p-tert-butylphenyl) -2 -methylpropyl] -cis-2, 6-dimethyl-morpholine, N- [3- (p-tert-butylphenyl) -2-methylpropyl] -piperidine, (8- (1, 1-dimethylethyl) -N- ethyl-N-propyl-1,4-dioxaspiro [4.5] decane-2-methanamine,
• Azole wie 1- [2- (2, 4-Dichlorphenyl) -4-ethyl-l, 3-dioxolan-2-yl- ethyl] -lH-l,2,4-triazol, 1- [2- (2, 4-Dichlorphenyl) -4-n-pro- pyl-1, 3-dioxolan-2-yl-ethyl] -1H-1, 2, 4-triazol, N- (n-Pro- pyl) -N- (2, 4, 6-trichlorphenoxyethyl) -N' -imidazol-yl-harnstoff , 1- (4-Chlorphenoxy) -3, 3-dimethyl-l- (1H-1, 2, 4-triazol-l-yl) -2-bu- tanon, 1- (4-Chlorphenoxy) -3 , 3-dimethyl-l- (1H-1,2, 4-tria- zol-l-yl)-2-butanol, (2RS, 3RS) -1- [3- (2-Chlorphenyl) -2- (4-fluor- phenyl)-oxiran-2-ylmethyl] -1H-1, 2, 4-triazol, 1- [2- (2 , 4-Dichlor- phenyD-pentyl] -1H-1, 2, 4-triazol, 2, 4 ' -Difluor- α- (1H-1, 2, 4-triazolyl-l-methyl) -benzhydrylalkohol, , 1- ( (bis- (4-Fluorphenyl) -methylsilyl) -methyl) -1H-1, 2, 4-triazol, 1- [2RS, 4RS;2RS, 4SR) -4-brom-2- (2 , 4-dichlorphenyl) tetrahydrofu- ryl] -lH-l,2,4-triazol, 2-- (4-Chlorphenyl) -3-cyclopro- pyl-1- (1H-1, 2, 4-triazol-l-yl) -butan-2-ol,Azoles such as 1- [2- (2,4-dichlorophenyl) -4-ethyl-l, 3-dioxolan-2-yl-ethyl] -IH-l, 2,4-triazole, 1- [2- (2nd , 4-dichlorophenyl) -4-n-propyl-1,3-dioxolan-2-yl-ethyl] -1H-1,2,4-triazole, N- (n-propyl) -N- ( 2, 4, 6-trichlorophenoxyethyl) -N '-imidazol-yl-urea, 1- (4-chlorophenoxy) -3, 3-dimethyl-l- (1H-1, 2, 4-triazol-l-yl) - 2-butanone, 1- (4-chlorophenoxy) -3, 3-dimethyl-l- (1H-1,2, 4-triazol-l-yl) -2-butanol, (2RS, 3RS) - 1- [3- (2-chlorophenyl) -2- (4-fluoro-phenyl) -oxiran-2-ylmethyl] -1H-1,2,4-triazole, 1- [2- (2,4-dichloro- phenyD-pentyl] -1H-1, 2, 4-triazole, 2, 4 '-difluoro- α- (1H-1, 2, 4-triazolyl-l-methyl) -benzhydryl alcohol,, 1- ((bis- (4-fluorophenyl) -methylsilyl) -methyl) -1H-1, 2, 4-triazole, 1 - [2RS, 4RS; 2RS, 4SR) -4-bromo-2- (2, 4-dichlorophenyl) tetrahydrofuryl] -lH-l, 2,4-triazole, 2-- (4-chlorophenyl) -3- cyclopropyl-1- (1H-1,2,4-triazol-l-yl) butan-2-ol,
(+) -4-Chlor-4- [4-methyl-2- (1H-1, 2, 4-triazol-l-ylme- thyl) -1, 3-dioxolan-2-yl] -phenyl-4-chlorphenylether,(+) -4-chloro-4- [4-methyl-2- (1H-1,2,4-triazol-l-ylmethyl) -1, 3-dioxolan-2-yl] phenyl-4- chlorophenyl ether,
(E) - (R, S) -1- (2 , 4-dichlorphenyl) -4, 4-dimethyl-2- (1H-1, 2 , 4-tria- zol-l-yl)pent-l-en-3-ol, 4- (4-Chlorphenyl) -2-phe- nyl-2- (1H-1, 2,4, -triazolylmethyl) -butyronitril, 3- (2, 4-dichlor- phenyl) -6-fluor-2- (1H-1, 2, 4-triazol-l-yl) chinazolin-4 (3H) -on, (R,S)-2- (2,4-Dichlorphenyl)-l-H-l,2,4-triazol-l-yl)-hex- ano-2-ol, (1RS, 5RS; 1RS, 5SR) -5- (4-chlorbenzyl) -2 , 2-dime- thyl-1- (1H-1, 2 , 4-triazol-l-ylmethyl) cyclopentanol, (R,S)-1- (4-chlorphenyl)-4,4-dimethyl-3- (1H-1, 2, 4-triazol-l-yl- methyl)pentan-3-ol, (+) -2- (2,4, -Dichlorphe- nyl)-3- ( 1H-1, 2,4-triazolyl) -propyl-1 ,1,2,2-tetrafluorethy- lether, (E) -1- [1- [4-Chlor-2-trifluormethyl) -phe- nyl] -imino) -2-propoxyethyl] -lH-imidazol, 2- (4-Chlorphe- nyl) -2- (1H-1, 2 , 4-triazol-l-ylmethyl) -hexannitril, α- (2-Chlorphenyl) -α- (4-chlorphenyl) -5-pyrimidin-methanol, 5-Bu- tyl-2-dimethylamino-4-hydroxy-6-methyl-pyrimidin, Bis- (p-chlor- phenyl) -3-pyridinmethanol, 1 , 2-Bis- (3-ethoxycarbonyl-2-thiou- reido) -benzol, 1, 2-Bis- (3-methoxycarbonyl-2-thioureido) -benzol,(E) - (R, S) -1- (2,4-dichlorophenyl) -4,4-dimethyl-2- (1H-1,2,4-triazol-l-yl) pent-l-ene -3-ol, 4- (4-chlorophenyl) -2-phenyl-2- (1H-1, 2,4, -triazolylmethyl) butyronitrile, 3- (2, 4-dichlorophenyl) -6- fluoro-2- (1H-1,2,4-triazol-l-yl) quinazolin-4 (3H) -one, (R, S) -2- (2,4-dichlorophenyl) -lHl, 2,4- triazol-l-yl) -hex-ano-2-ol, (1RS, 5RS; 1RS, 5SR) -5- (4-chlorobenzyl) -2, 2-dimethyl-1- (1H-1, 2, 4-triazol-l-ylmethyl) cyclopentanol, (R, S) -1- (4-chlorophenyl) -4,4-dimethyl-3- (1H-1, 2, 4-triazol-l-ylmethyl) pentane -3-ol, (+) -2- (2,4, -dichlorophenyl) -3- (1H-1, 2,4-triazolyl) propyl-1, 1,2,2-tetrafluoroethyl ether, (E) -1- [1- [4-chloro-2-trifluoromethyl) phenyl] imino) -2-propoxyethyl] 1 H -imidazole, 2- (4-chlorophenyl) -2- (1H -1, 2, 4-triazol-l-ylmethyl) hexanitrile, α- (2-chlorophenyl) -α- (4-chlorophenyl) -5-pyrimidine-methanol, 5-butyl-2-dimethylamino-4- hydroxy-6-methyl-pyrimidine, bis- (p-chlorophenyl) -3-pyridine-methanol, 1,2-bis- (3-ethoxycarbonyl-2-thiou-reido) -benzene, 1,2-bis- (3-methoxycarbonyl-2-thioureido) -benzene,
Strobilurine wie Methyl-E-methoxyimino- [α- (o-tolyloxy) -o-to- lyl] acetat, Methyl-E-2-{2- [6- (2-cyanophenoxy) -pyrimi- din-4-yloxy] -phenyl} -3-methoxyacrylat, Methyl-E-methoxyimino- [α- (2- phenoxyphenyl) ] -acetamid, Methyl-E-methoxyimino- [α- (2, 5-dime- thylphenoxy) -o-tolyl] -acetamid,Strobilurins such as methyl-E-methoxyimino- [α- (o-tolyloxy) -o-tolyl] acetate, methyl-E-2- {2- [6- (2-cyanophenoxy) pyrimidine-4-yloxy ] -phenyl} -3-methoxyacrylate, methyl-E-methoxyimino- [α- (2-phenoxyphenyl)] acetamide, methyl-E-methoxyimino- [α- (2, 5-dimethylphenoxy) -o-tolyl] -acetamide,
• Anilinopyrimidine wie N- (4 , 6-Dimethylpyrimidin-2-yl) -anilin, N- [4-Methyl-6- (1-propinyl) -pyrimidin-2-yl] -anilin,Anilinopyrimidines such as N- (4, 6-dimethylpyrimidin-2-yl) aniline, N- [4-methyl-6- (1-propynyl) pyrimidin-2-yl] aniline,
N- [4-Methyl-6-cyclopropyl-pyrimidin-2-yl] -anilin, • Phenylpyrrole wie 4- (2, 2-Difluor-1, 3-benzodioxol-4-yl) -pyr- rol-3-carbonitril,N- [4-methyl-6-cyclopropyl-pyrimidin-2-yl] aniline, • phenylpyrroles such as 4- (2, 2-difluoro-1, 3-benzodioxol-4-yl) pyrrole-3-carbonitrile ,
• Zimtsäureamide wie 3- (4-Chlorphenyl) -3- (3 , 4-dimethoxyphe- nyl) -acrylsäuremorpholid, sowie verschiedene Fungizide, wie Dodecylguanidinacetat, 3- [3- (3 , 5-Dimethyl-2-oxycyclohexyl) -2-hydroxyethyl] -glutarimid, N- Methyl-, N-ethyl- (4-trifluormethyl, -2- [3' , 4 ' -dimethoxyphe- nyl] -benzoesäureamid, Hexachlorbenzol, DL-Methyl-N- (2, 6-dime- thyl-phenyl) -N-furoyl (2) -alaninat, DL-N- (2, 6-Dimethyl-phe- nyl) -N- (2' -methoxyacetyl) -alanin-methyl- ester, N-(2,6-Dime- thylphenyl) -N-chloracetyl-D, -2-aminobutyrolacton, DL- N- (2 , 6-Dimethylphenyl) -N- (phenylacetyl) -alaninmethylester, 5-Methyl-5-vinyl-3- (3, 5-dichlorphenyl) -2 , 4-dioxo-l, 3-oxazoli- din, 3- [3, 5-Dichlorphenyl (-5-methyl-5-methoxymethyl] -1, 3-oxazo- lidin- 2,4-dion, 3- (3, 5-Dichlorphenyl) -1-isopropylcarbamoylhy- dantoin, N- (3, 5-Dichlorphenyl) -1, 2-dimethylcyclopropan-l, 2-di- carbonsäureimid, 2-Cyano- [N- (ethylaminocarbonyl) -2-methoxi- 5 mino] -acetamid, N- (3-Chlor-2, 6-dinitro-4-trifluormethyl-phe- nyl) -5-trifluormethyl-3-chlor-2-aminopyridin• Cinnamic acid amides such as 3- (4-chlorophenyl) -3- (3, 4-dimethoxyphenyl) acrylic morpholide, as well as various fungicides, such as dodecylguanidine acetate, 3- [3- (3, 5-dimethyl-2-oxycyclohexyl) -2 -hydroxyethyl] -glutarimide, N-methyl-, N-ethyl- (4-trifluoromethyl, -2- [3 ', 4' -dimethoxyphenyl] -benzoic acid amide, hexachlorobenzene, DL-methyl-N- (2, 6- dimethyl-phenyl) -N-furoyl (2) -alaninate, DL-N- (2, 6-dimethyl-phenyl) -N- (2'-methoxyacetyl) -alanine-methyl-ester, N- ( 2,6-dimethylphenyl) -N-chloroacetyl-D, -2-aminobutyrolactone, DL-N- (2,6-dimethylphenyl) -N- (phenylacetyl) -alanine methyl ester, 5-methyl-5-vinyl-3- (3, 5-dichlorophenyl) -2, 4-dioxo-l, 3-oxazoli- din, 3- [3,5-dichlorophenyl (-5-methyl-5-methoxymethyl] -1,3-oxazolidine-2,4-dione, 3- (3,5-dichlorophenyl) -1-isopropylcarbamoylhydantoin , N- (3, 5-dichlorophenyl) -1, 2-dimethylcyclopropane-l, 2-dicarboximide, 2-cyano- [N- (ethylaminocarbonyl) -2-methoxi- 5 mino] -acetamide, N- (3rd -Chlor-2, 6-dinitro-4-trifluoromethyl-phenyl) -5-trifluoromethyl-3-chloro-2-aminopyridine
Funktionen äquivalente Derivate dieser Fungizide besitzen ein u vergleichbares Wirkungsspektrum gegen phytopathogene Pilze wie die konkret genannten Substanzen, bei niedrigerer, gleicher oder höherer phytotoxischer Aktivität.Functions equivalent derivatives of these fungicides have a u comparable spectrum of activity against phytopathogenic fungi as the specifically named substances, with lower, the same or higher phytotoxic activity.
Die Erfindung wird durch die nun folgenden Beispiele erläutert, 5 ist aber nicht auf diese beschränkt:The invention is illustrated by the following examples, but FIG. 5 is not restricted to these:
Allgemeine KlonierungsverfahrenGeneral cloning procedures
0 Die im Rahmen der vorliegenden Erfindung durchgeführten Klonie- rungsschritte wie z.B. Restriktionsspaltungen, Agarose-Gel- elektrophorese, Reinigung von DNA-Fragmenten, Transfer von Nukleinsäuren auf Nitrozellulose und Nylonmembranen, Verknüpfen von DNA-Fragmenten, Transformation von E. coli Zellen, Anzucht von 5 Bakterien, Vermehrung von Phagen und Sequenzanalyse rekombinanter DNA wurden wie bei Sambrook et al . (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6) beschrieben durchgeführt.0 The cloning steps carried out in the context of the present invention, such as Restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking of DNA fragments, transformation of E. coli cells, cultivation of 5 bacteria, multiplication of phages and sequence analysis of recombinant DNA were as in Sambrook et al. (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6).
Die im folgenden verwendeten Bakterienstämme (E. coli, XL-I Blue) ^ wurden von Stratagene bezogen. Der zur Pflanzentransformation verwendete Agrobakterienstamm (Agrobacterium tumefaciens, C58C1 mit dem Plasmid pGV2260 oder pGV3850kan) wurde von Deblaere et al. beschrieben (Nucl. Acids Res . 13 (1985) 4777). Alternativ können auch der Agrobakterienstamm LBA4404 (Clontech) oder andere 5 geeignete Stämme eingesetzt werden. Zur Klonierung wurden die Vektoren pUC19 (Yanish-Perron, Gene 33 (1985) , 103-119) pBlues- cript SK- (Stratagene) , pGEM-T (Promega) , pZerO (Invitrogen) , pBinl9 (Bevan et al., Nucl. Acids Res. 12(1984) 8711-8720) und pBinAR (Höfgen und Willmitzer, Plant Science 66 (1990) 221-230) 0 benutzt.The bacterial strains used below (E. coli, XL-I Blue) ^ were obtained from Stratagene. The Agrobacterium strain used for plant transformation (Agrobacterium tumefaciens, C58C1 with the plasmid pGV2260 or pGV3850kan) was developed by Deblaere et al. (Nucl. Acids Res. 13 (1985) 4777). Alternatively, the agrobacterial strain LBA4404 (Clontech) or other 5 suitable strains can be used. For cloning, the vectors pUC19 (Yanish-Perron, Gene 33 (1985), 103-119) pBlues- script SK- (Stratagene), pGEM-T (Promega), pZerO (Invitrogen), pBinl9 (Bevan et al., Nucl Acids Res. 12 (1984) 8711-8720) and pBinAR (Höfgen and Willmitzer, Plant Science 66 (1990) 221-230) 0 .
Sequenzanalyse rekombinanter DNASequence analysis of recombinant DNA
Die Sequenzierung rekombinanter DNA-Moleküle erfolgte mit einem Laserfluoreszenz-DNA-Sequenzierer der Firma Pharmacia nach der Methode von Sanger (Sanger et al . , Proc. Natl. Acad. Sei. USA 74 (1977) , 5463-5467) .The sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from Pharmacia according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sei. USA 74 (1977), 5463-5467).
Erzeugung pflanzlicher ExpressionskassettenProduction of plant expression cassettes
55
In das Plasmid pBinl9 (Bevan et al., Nucl. Acids Res. 12, 8711In plasmid pBin19 (Bevan et al., Nucl. Acids Res. 12, 8711
(1984)) wurde ein 35S CaMV Promotor als EcoRI-Kpnl-Fragment (entsprechend den Nukleotiden 6909-7437 des Cauliflower-Mosaik- Virus (Franck et al . Cell 21 (1980) 285) inseriert. Das Polyade- nylierungssignal des Gens 3 der T-DNA des Ti-Plasmides pTiACH5(1984)), a 35S CaMV promoter was inserted as an EcoRI-Kpnl fragment (corresponding to nucleotides 6909-7437 of the Cauliflower mosaic virus (Franck et al. Cell 21 (1980) 285). The polyadenylation signal of gene 3 der T-DNA of the Ti plasmid pTiACH5
10 (Gielen et al . , EMBO J. 3 (1984) 835), Nukleotide 11749-11939 wurde als PvuII-Hindlll-Fragment isoliert und nach Addition von Sphl-Linkern an die PvuII-Schnittstelle zwischen die SpHI-Hindlll Schnittstelle des Vektors kloniert. Es entstand das Plasmid pBi- nAR (Höfgen und Willmitzer, Plant Science 66 (1990) 221-230) .10 (Gielen et al., EMBO J. 3 (1984) 835), nucleotides 11749-11939 was isolated as a PvuII-HindIII fragment and cloned between the SpHI-HindIII interface of the vector after addition of Sphl linkers to the PvuII interface . The plasmid pBinAR was formed (Höfgen and Willmitzer, Plant Science 66 (1990) 221-230).
1515
AnwendungsbeispieleExamples of use
Beispiel 1example 1
2020th
Da Fungizide nicht immunogen sind, müssen sie an ein Trägermaterial wie z.B. KLH gekoppelt werden. Befindet sich eine reaktive Gruppe im Molekül, kann diese Kopplung direkt erfolgen, ansonsten wird während der Synthese des Fungizides eine funktio-Since fungicides are not immunogenic, they have to be attached to a carrier material such as e.g. KLH can be coupled. If there is a reactive group in the molecule, this coupling can take place directly, otherwise a functional function is carried out during the synthesis of the fungicide.
25 nelle Gruppe eingeführt oder eine reaktive Vorstufe während der Synthese ausgesucht, um diese Moleküle in einem einfachen Reaktionsschritt an das Trägermolekül zu koppeln. Beispiele für Kopplungen sind bei Miroslavic Ferencik in "Handbook of Immunoche- mistry" , 1993, Chapman & Hall, im Kapitel Antigene, Seite 20 -25 nelle group introduced or a reactive precursor selected during the synthesis in order to couple these molecules to the carrier molecule in a simple reaction step. Examples of couplings are given by Miroslavic Ferencik in "Handbook of Immunochemistry", 1993, Chapman & Hall, in the chapter Antigens, page 20 -
30 49 beschrieben.30 49 described.
Durch wiederholte Injektion dieses modifizierten Trägermoleküls (Antigens) werden z.B. Balb/c-Mäuse immunisiert. Sobald im Serum genügend Antikörper mit Bindung an das Antigen im ELISA (enzymeBy repeated injection of this modified carrier molecule (antigen) e.g. Balb / c mice immunized. As soon as there is enough antibody in the serum to bind to the antigen in the ELISA (enzyme
35 linked immuno sorbent assay) nachweisbar sind, werden die Milz- zellen dieser Tiere entnommen und mit Myelomzellen fusioniert um Hybride zu kultivieren. Im ELISA wird zusätzlich als Antigen "Fungizid-modifiziertes BSA" verwendet, um die gegen das Hapten gerichtete Immunantwort von der KLH-Antwort zu unterscheiden. 035 linked immunosorbent assay) are detectable, the spleen cells of these animals are removed and fused with myeloma cells in order to cultivate hybrids. In the ELISA "fungicide-modified BSA" is also used as an antigen to distinguish the immune response against the hapten from the KLH response. 0
Die Herstellung von monoklonalen Antikörpern erfolgt in Anlehnung an bekannte Methoden, wie z.B. beschrieben in "Practical Immuno- logy" , Leslie Hudson und Frank Hay, Blackwell Scientific 5 Publications, 1989 oder in "Monoclonal Antibodies: Principles and Practice" , James Goding, 1983, Academic Press, Inc., oder in "A practical guide to monoclonal antibodies", J.Liddell und A. Cryer,1991, John Wiley& Sons; oder Achim Möller und Franz Emling "Monokonale Antikörper gegen TNF und deren Verwendung". Europäische Patentschrift EP-A260610.Monoclonal antibodies are produced based on known methods, as described, for example, in "Practical Immunology", Leslie Hudson and Frank Hay, Blackwell Scientific 5 Publications, 1989 or in "Monoclonal Antibodies: Principles and Practice", James Goding, 1983 , Academic Press, Inc., or in "A practical guide to monoclonal antibodies", J. Liddell and A. Cryer, 1991, John Wiley &Sons; or Achim Möller and Franz Emling "Monoconal antibodies against TNF and their use". European patent EP-A260610.
5 Beispiel 2 5 Example 2
Ausgangspunkt der Untersuchung war ein monoklonaler Antikörper der spezifisch das Fungizid BAS 490F erkennt und der außerdem eine hohe Bindungsaffinität aufweist. Die selektionierte Hybrido- 0 mazellinie ist dadurch charakterisiert, daß die sekretierten, gegen das Fungizid-Antigen BAS 490F gerichteten monoklonalen Antikörper eine hohe Affinität aufweisen und die spezifischen Sequenzen der Immunglobuline verfügbar sind (Berek, C. et al., Nature 316, 412-418, 1985) . Dieser monoklonale Antikörper gegen BAS 490F 5 war Ausgangspunkt für die Konstruktion des Einketten-Antikörper- fragmentes (scFv-antiBAS 490F) .The starting point for the investigation was a monoclonal antibody that specifically recognizes the BAS 490F fungicide and also has a high binding affinity. The selected hybrid cell line is characterized in that the secreted monoclonal antibodies directed against the fungicide antigen BAS 490F have a high affinity and the specific sequences of the immunoglobulins are available (Berek, C. et al., Nature 316, 412- 418, 1985). This monoclonal antibody against BAS 490F 5 was the starting point for the construction of the single-chain antibody fragment (scFv-antiBAS 490F).
Zunächst wurde mRNA aus den Hybridomzeilen isoliert und in cDNA o umgeschrieben. Diese cDNA diente als Matrize für die Amplifika - tion der variablen Immunglobulingene VH und VK mit den spezifischen Primern VH1 BACK und VH FOR-2 für die schwere Kette sowie VK2 BACK und MJK5 FON X für die leichte Kette (Clackson et al., Nature 352, 624-628, 1991). Die isolierten variablen Immunglobu- 5 line waren Ausgangspunkt für die Konstruktion eines Einketten-An- tikörperfragmentes (scFv-antiBAS 490F) . Bei der nachfolgenden Fu- sions- PCR wurden drei Komponenten VH,VK und ein Linkerfragment in einem PCR-Reaktionsansatz vereinigt und das scFv-antiBAS 49OF amplifiziert (Abb. 3 ). 0First, mRNA was isolated from the hybridoma cells and rewritten into cDNA o. This cDNA served as a template for the amplification of the variable immunoglobulin genes VH and VK with the specific primers VH1 BACK and VH FOR-2 for the heavy chain and VK2 BACK and MJK5 FON X for the light chain (Clackson et al., Nature 352 , 624-628, 1991). The isolated variable immunoglobulin lines were the starting point for the construction of a single-chain antibody fragment (scFv-antiBAS 490F). In the subsequent fusion PCR, three components VH, VK and a linker fragment were combined in a PCR reaction mixture and the scFv-antiBAS 49OF was amplified (Fig. 3). 0
Die funktionelle Charakterisierung (Antigenbindungsaktivität) des konstruierten scFv-antiBAS 490F-Gens erfolgte nach Expression in einem bakteriellen System. Das scFv-antiBAS 49OF wurde dazu nach der Methode von Hoogenboom, H.R. et al., Nucleic Acids Re- search 19, 4133-4137, 1991 als lösliches Antikörperfragment in E.coli synthetisiert. Die Aktivität und die Spezifität des konstruierten Antikörperfragmentes wurden in ELISA-Tests überprüf (Abb .4 ) .The functional characterization (antigen binding activity) of the constructed scFv-antiBAS 490F gene was carried out after expression in a bacterial system. The scFv-antiBAS 49OF was made using the method of Hoogenboom, H.R. et al., Nucleic Acids Research 19, 4133-4137, 1991 as a soluble antibody fragment in E. coli. The activity and the specificity of the constructed antibody fragment were checked in ELISA tests (Fig. 4).
Um eine samenspezifische Expression des Antikörperfragmentes in Tabak zu ermöglichen, wurde das scFv-antiBAS 490F Gen stromabwärts vom LeB4-Promotor kloniert. Der aus Vicia faba isolierte LeB4-Promotor zeigt eine streng samenspezifische Expression von verschiedenen Fremdgenen in Tabak (Bäumlein, H. et al., Mol. Gen. Genet. 225, 121-128, 1991). Durch Transport des scFv-antiBAS 490F Polypeptides in das endoplasmatische Retikulum wurde eine stabile Akkumulation hoher Antikörperfragmentmengen erreicht. Das scFv- antiBAS 490F Gen wurde zu diesem Zweck mit einer Signalpeptidse- quenz, die den Eintritt in das endoplasmatische Retikulum und dem ER-Retentionssignal SEKDEL, das ein Verbleiben im ER gewährleistet (Wandelt et al.,1992), fusioniert (Abb. 5 ). 5To enable seed-specific expression of the antibody fragment in tobacco, the scFv-antiBAS 490F gene was cloned downstream of the LeB4 promoter. The LeB4 promoter isolated from Vicia faba shows a strictly seed-specific expression of various foreign genes in tobacco (Bäumlein, H. et al., Mol. Gen. Genet. 225, 121-128, 1991). By transporting the scFv-antiBAS 490F polypeptide into the endoplasmic reticulum, a stable accumulation of large amounts of antibody fragments was achieved. The scFv For this purpose, the antiBAS 490F gene was merged with a signal peptide sequence that fuses entry into the endoplasmic reticulum and the ER retention signal SEKDEL, which ensures that it remains in the ER (Wandelt et al., 1992) (Fig. 5). 5
Die konstruierte Expressionskassette wurde in den binären Vektor pGSGLUC 1 (Saito et al . , 1990) kloniert und durch Elektroporation in den Agrobakterium-Stamm EHA 101 transferiert. Rekombinante Agrobakterienklone wurden für die nachfolgende Transformation von x" Nicotiana tabacum verwendet. Pro Konstrukt wurden 70-140 Tabakpflanzen regeneriert. Von den regenerierten transgenen Tabakpflanzen wurden nach Selbstbefruchtung Samen verschiedenener Entwicklungsstadien geerntet. Von diesen Samen wurden die löslichen Proteine nach Extraktion in einem wässrigen Puffersystem erhal-The constructed expression cassette was cloned into the binary vector pGSGLUC 1 (Saito et al., 1990) and transferred into the Agrobacterium strain EHA 101 by electroporation. Recombinant agrobacterial clones were used for the subsequent transformation of x "Nicotiana tabacum. 70-140 tobacco plants were regenerated per construct. From the regenerated transgenic tobacco plants, seeds of various developmental stages were harvested after self-fertilization. From these seeds, the soluble proteins were obtained after extraction in an aqueous buffer system -
" ten. Die Analyse der transgenen Pflanzen zeigt, daß durch die Fusion des scFv-antiBAS 490F Gens mit der DNA-Sequenz des ER-Reten- tionssignals SEKDEL eine maximale Akkumulation von 1,9 % scFv-an- tiBAS 490F Protein im reifen Samen erzielt werden konnte. "th. The analysis of the transgenic plants demonstrates that by the fusion of the scFv-antiBAS 490F gene to the DNA sequence of the ER-tion retentate signal SEKDEL mature a maximum accumulation of 1.9% scFv-antiBAS 490F protein in Seeds could be obtained.
2020th
Das konstruierte scFv-antiBAS 490F Gen hatte eine Große von ca.The constructed scFv-antiBAS 490F gene had a size of approx.
735 bp. Die variablen Domänen wurden in der Reihenfolge VH-L-VL miteinander fusioniert.735 bp. The variable domains were fused together in the order VH-L-VL.
25 Die spezifische Selektivität wurde in den Extrakten der reifen Tabaksamen mit einem direkten ELISA bestimmt. Die dabei erhaltenen Werte zeigen deutlich, daß die Proteinextrakte funktioneil aktive Antikörperfragmente enthalten.25 The specific selectivity was determined in the extracts of the ripe tobacco seeds using a direct ELISA. The values obtained show clearly that the protein extracts contain functionally active antibody fragments.
0 Beispiel 30 Example 3
Samenspezifische Expression und Anreicherung von Einketten-Anti- körperfragmenten im endoplasmatischen Retikulum von Zellen transgener Tabaksamen kontolliert durch den USP- Promotor. 5Seed-specific expression and enrichment of single-chain antibody fragments in the endoplasmic reticulum of cells of transgenic tobacco seeds controlled by the USP promoter. 5
Ausgangspunkt der Untersuchungen war ein Einzelketten-Antikörper - fragment gegen das Fungizid BAS 490F (scFv-anti BAS 490F) . Die funktioneile Charakterisierung (Antigenbindungsaktivität) dieses konstruierten scFv-anti- BAS 490F Genes erfolgte nach Expression 0 in einem bakteriellen System und nach Expression in Tabakblättern. Die Aktivität und die Spezifität des konstruierten Antikörperfragmentes wurde in ELISA-Tests überprüft.The starting point for the investigations was a single chain antibody fragment against the fungicide BAS 490F (scFv-anti BAS 490F). The functional characterization (antigen binding activity) of this constructed scFv-anti-BAS 490F gene was carried out after expression 0 in a bacterial system and after expression in tobacco leaves. The activity and the specificity of the antibody fragment constructed was checked in ELISA tests.
5 Um eine samenspezifische Expression des Antikörperfragmentes in Tabak zu ermöglichen, wurde das scFv-antiBAS 490F Gen stromabwärts vom USP-Promotor kloniert. Der aus Vicia faba isolierte ι-Λ5 To enable seed-specific expression of the antibody fragment in tobacco, the scFv-antiBAS 490F gene was cloned downstream of the USP promoter. The one isolated from Vicia faba ι-Λ
Figure imgf000023_0001
Figure imgf000023_0001
terial wurden die löslichen Proteine nach Extraktion in einem wässrigen Puffersystem erhalten. Nachfolgende Analysen (Western- Blot-Analysen und ELISA-Tests) zeigten, daß in den Blättern eine maximale Akkumulation von größer 2 % an biologisch aktivem, anti- 5 genbindendem scFv-antiBAS 490F Polypeptid erzielt werden konnte. Die hohen Expressionswerte wurden in ausgewachsenen grünen Blättern ermittelt, aber auch in seneszentem Blattmaterial konnte das Antikörperfragment nachgewiesen werden.The soluble proteins were obtained after extraction in an aqueous buffer system. Subsequent analyzes (Western blot analyzes and ELISA tests) showed that a maximum accumulation of greater than 2% of biologically active, antigen-binding scFv-antiBAS 490F polypeptide could be achieved in the leaves. The high expression values were determined in adult green leaves, but the antibody fragment could also be detected in senescent leaf material.
10 Beispiel 510 Example 5
PCR-Amplifikation eines Fragmentes der cDNA codierend für den Ein-Ketten-Antikörper gegen BAS 490F mithilfe synthetischer Oligonukleotide.PCR amplification of a fragment of the cDNA coding for the single-chain antibody against BAS 490F using synthetic oligonucleotides.
1515
Die PCR-Amplikation der Ein-Ketten-Antikörper cDNA wurde in einem DNA-Thermal Cycler der Firma Perkin Eimer durchgeführt. Die Reaktionsgemische enthielten 8 ng/μl einzelsträngige Matrizen- 20 cDNA , 0,5 μM der entsprechenden Oligonukleotide,The PCR amplification of the one-chain antibody cDNA was carried out in a DNA thermal cycler from Perkin Elmer. The reaction mixtures contained 8 ng / μl of single-stranded template 20 cDNA, 0.5 μM of the corresponding oligonucleotides,
200 μM Nukleotide (Pharmacia), 50 mM KC1, 10 M Tris-HCl (pH 8,3 bei 25oC, l,5mM MgC12) und 0.02 U/μl Taq Polymerase (Perkin Eimer) . Die Amplifikationsbedingungen wurden wie folgt eingestellt:200 μM nucleotides (Pharmacia), 50 mM KC1, 10 M Tris-HCl (pH 8.3 at 25oC, 1.5mM MgC12) and 0.02 U / μl Taq polymerase (Perkin Elmer). The amplification conditions were set as follows:
25 Anlagerungstemperatur: 45°C25 annealing temperature: 45 ° C
Denaturierungstemperatur : 94°C,Denaturation temperature: 94 ° C,
Elongationstemperatur: 72°C,Elongation temperature: 72 ° C,
Anzahl der Zyklen: 40Number of cycles: 40
•an•on
Es resultierte ein Fragment von ca. 735 Basenpaaren, das m denThe result was a fragment of approximately 735 base pairs, the m den
Vektor pBluescript ligiert wurde. Mit dem Ligationsansatz wurde E. coli XL-I Blue transformiert und das Plasmid amplifiziert . Zur Anwendung und Optimierung der Polymerase Kettenreaktion siehe: Innis et al., 1990, PCR Protocols, a Guide to Methods and Ap- plications, Academic Press.Vector pBluescript was ligated. E. coli XL-I Blue was transformed with the ligation mixture and the plasmid was amplified. For application and optimization of the polymerase chain reaction see: Innis et al., 1990, PCR Protocols, a Guide to Methods and Applications, Academic Press.
Beispiel 6Example 6
0 Herstellung transgener Tabakpflanzen, die eine cDNA codierend für einen Ein-Ketten-Antikörper mit Fungizid-bindenden Eigenschaften exprimieren.Production of transgenic tobacco plants which express a cDNA coding for a single-chain antibody with fungicide-binding properties.
Das Plasmid pGSGLUC 1 wurde in Agrobacterium tumefaciens 5 C58Cl:pGV2260 transformiert. Zur Transformation von Tabakpflanzen (Nicotiana tabacum cv. Samsun NN) wurde eine 1:50 Verdünnung einer Übernachtkultur einer positiv transformierten Agrobakte- rienkolonie in Murashige-Skoog Medium (Physiol. Plant. 15 (1962) 473 ff.) mit 2% Saccharose (2MS-Medium) benutzt. Blattscheiben steriler Pflanzen (zu je ca. 1 cm2) wurden in einer Petrischale mit einer 1:50 Agrobakterienverdünnung für 5-10 Minuten inkubiert. Es folgte eine 2-tägige Inkubation in Dunkelheit bei 25°C auf 2MS-Medium mit 0,8% Bacto-Agar. Die Kultivierung wurde nach 2 Tagen mit 16 Stunden Licht/8 Stunden Dunkelheit weitergeführt und in wöchentlichem Rhythmus auf MS-Mediu mit 500 mg/1 Claforan (Cefotaxime-Natrium) , 50 mg/1 Kanamycin, 1 mg/1 Benzyla- minopurin (BAP), 0,2 mg/1 Naphtylessigsäure und 1,6 g/1 Glukose weitergeführt. Wachsende Sprosse wurden auf MS-Medium mit 2% Saccharose, 250 mg/1 Claforan und 0,8% Bacto-Agar überführt.The plasmid pGSGLUC 1 was transformed into Agrobacterium tumefaciens 5 C58Cl: pGV2260. For the transformation of tobacco plants (Nicotiana tabacum cv. Samsun NN) a 1:50 dilution of an overnight culture of a positively transformed agrobact colony in Murashige-Skoog medium (Physiol. Plant. 15 (1962) 473 ff.) with 2% sucrose (2MS medium). Leaf disks of sterile plants (each about 1 cm 2 ) were incubated in a Petri dish with a 1:50 agrobacterial dilution for 5-10 minutes. This was followed by a 2-day incubation in the dark at 25 ° C. on 2MS medium with 0.8% Bacto agar. The cultivation was continued after 2 days with 16 hours of light / 8 hours of darkness and on a weekly basis on MS medium with 500 mg / 1 claforan (cefotaxime sodium), 50 mg / 1 kanamycin, 1 mg / 1 benzylaaminopurine (BAP ), 0.2 mg / 1 naphthylacetic acid and 1.6 g / 1 glucose continued. Growing shoots were transferred to MS medium with 2% sucrose, 250 mg / 1 Claforan and 0.8% Bacto agar.
Beispiel 7Example 7
Stabile Akkumulation des Einketten-Antikörperfragmentes gegen das Fungizid BAS 490F im endoplasmatischen Reticulum.Stable accumulation of the single-chain antibody fragment against the fungicide BAS 490F in the endoplasmic reticulum.
Ausgangspunkt der Untersuchungen war ein in Tabakpflanzen expri - miertes Einketten-Antikörperfragment gegen das Fungizid BAS 490F (scFv-anti BAS 490F) . Menge und Aktivität des synthetisierten scFv-antiBAS 490F Polypeptides wurden in Western-Blot-Analysen und ELISA-Tests bestimmt.The starting point of the investigations was a single-chain antibody fragment expressed against the fungicide BAS 490F (scFv-anti BAS 490F) expressed in tobacco plants. The amount and activity of the synthesized scFv-antiBAS 490F polypeptide were determined in Western blot analyzes and ELISA tests.
Um eine Expression des scFv-antiBAS 490F-Gens im endoplasmatischen Retikulum zu ermöglichen, wurde das Fremdgen unter der Kontrolle des CaMV 53S-Promotors als eine Translationsfusion mit dem LeB4-Signalpeptid (N-ter inal) und dem ER-Retentionssignal KDEL (C-terminal) exprimiert. Durch Transport des scFv-antiBAS 490F Polypeptids in das endoplasmatische Retikulum wurde eine stabile Akkumulation hoher Mengen an aktivem Antikörperfragment erreicht. Nach Ernte des Blattmaterials wurden Stücke bei -20°C eingefroren (1), lyophilisiert (2) oder bei Raumtemperatur ge- trocknet (3) . Die löslichen Proteine wurden aus dem jeweiligen Blattmaterial durch Extraktion in einem wässrigen Puffer erhalten und das scFv-antiBAS 490F Polpypeptid affinitatschromatographisch gereinigt. Gleiche Mengen an gereinigtem scFv-antiBAS 490F Polypeptids (eingefroren, lyophilisiert und getrocknet) wurden für die Bestimmung der Aktivität des Antikörperfragmentes eingesetzt (Abb. 6) .In Abb. 6 A ist die Antigenbindungsaktivität des aus frischen (1), lyophilisierten (2) und getrockneten Blättern (3) gereinigten scFv-antiBAS 490F Polypeptides dargestellt. In Abb. 6 B sind die jeweiligen Mengen an scFv-antiBAS 490F Protein (etwa 100 ng) , die für die ELISA-Analysen eingesetzt wurden, mittels Western-Blot-Analysen bestimmt. Die Größen der Proteinmolekulargewichtsstandards sind links dargestellt. Dabei wurden etwa gleiche Antigenbindungsaktivitäten festgestellt.To enable expression of the scFv-antiBAS 490F gene in the endoplasmic reticulum, the foreign gene was controlled under the control of the CaMV 53S promoter as a translation fusion with the LeB4 signal peptide (N-th inal) and the ER retention signal KDEL (C- terminal). By transporting the scFv-antiBAS 490F polypeptide into the endoplasmic reticulum, a stable accumulation of high amounts of active antibody fragment was achieved. After harvesting the leaf material, pieces were frozen at -20 ° C (1), lyophilized (2) or dried at room temperature (3). The soluble proteins were obtained from the respective leaf material by extraction in an aqueous buffer and the scFv-antiBAS 490F polpypeptide was purified by affinity chromatography. Equal amounts of purified scFv-antiBAS 490F polypeptide (frozen, lyophilized and dried) were used to determine the activity of the antibody fragment (Fig. 6). Fig. 6 A shows the antigen binding activity of the fresh (1), lyophilized (2) and dried leaves (3) of purified scFv-antiBAS 490F polypeptides. In Fig. 6 B the respective amounts of scFv-antiBAS 490F protein (about 100 ng), which were used for the ELISA analyzes, are determined by means of Western blot analyzes. The sizes of the protein molecular weight standards are shown on the left. Thereby about the same antigen binding activity was found.
Beispiel 8Example 8
Zum Nachweis der Fungizid-Toleranz der ein Polypeptid mit Fungizid-bindenden Eigenschaften produzierenden transgenen Tabakpflanzen wurden diese mit unterschiedlichen Mengen BAS 490F behandelt. In allen Fällen konnte im Gewächshaus gezeigt werden, daß die ein scFv-antiBAS 490F Gen exprimierenden Pflanzen im Vergleich zurTo demonstrate the fungicide tolerance of the transgenic tobacco plants producing a polypeptide with fungicide-binding properties, these were treated with different amounts of BAS 490F. In all cases it could be shown in the greenhouse that the plants expressing a scFv-antiBAS 490F gene compared to the
Kontrolle eine höhere Toleranz gegenüber dem Fungizid BAS 490F und geringere phytotoxische Wirkungen zeigen. Control show a higher tolerance to the fungicide BAS 490F and lower phytotoxic effects.

Claims

Patentansprüche claims
1. Verfahren zur Herstellung von Fungizid-toleranten Pflanzen durch Expression eines exogenen Fungizid-bindenden Polypeptids in den Pflanzen.1. Process for the production of fungicide-tolerant plants by expression of an exogenous fungicide-binding polypeptide in the plants.
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß es sich bei dem exogenen Fungizid-bindenden Polypeptid um ein x^ Einketten-Antikörperfragment handelt.2. The method according to claim 1, characterized in that the exogenous fungicide-binding polypeptide is an x ^ single-chain antibody fragment.
3. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß es sich bei dem exogenen Fungizid-bindenden Polypeptid um einen kompletten Antikörper oder um ein davon abgeleitetes Fragment3. The method according to claim 1, characterized in that the exogenous fungicide-binding polypeptide is a complete antibody or a fragment derived therefrom
15 handelt.15 acts.
4. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß es sich bei dem Fungizid um methyl methoxyimino-α- (o-toly- loxy)-o-tolylacetate ( BAS 490F ) handelt.4. The method according to claim 1, characterized in that the fungicide is methyl methoxyimino-α- (o-toly-loxy) -o-tolylacetate (BAS 490F).
2020th
5. Verfahren nach einem der Ansprüche 1 - 3, dadurch gekennzeichnet, daß es sich um mono- oder dikotyle Pflanzen handelt.5. The method according to any one of claims 1-3, characterized in that it is mono- or dicotyledonous plants.
25 6. Verfahren nach Anspruch 5, dadurch gekennzeichnet, daß es sich bei der Pflanze um Tabak handelt. 25 6. The method according to claim 5, characterized in that the plant is tobacco.
7. Verfahren nach einem der Ansprüche 1 - 6, dadurch gekennzeichnet, daß die Expression des exogenen Polypeptids konsti-7. The method according to any one of claims 1-6, characterized in that the expression of the exogenous polypeptide constant
30 tutiv in der Pflanze erfolgt.30 tutive in the plant.
8. Verfahren nach einem der Ansprüche 1 - 6, dadurch gekennzeichnet, daß die Expression des exogenen Polypeptids in der Pflanze induziert wird.8. The method according to any one of claims 1-6, characterized in that the expression of the exogenous polypeptide is induced in the plant.
3535
9. Verfahren nach einem der Ansprüche 1 - 6, dadurch gekennzeichnet, daß die Expression des exogenen Polypeptids in den Blättern der Pflanze erfolgt.9. The method according to any one of claims 1-6, characterized in that the expression of the exogenous polypeptide takes place in the leaves of the plant.
40 10. Verfahren nach einem der Ansprüche 1 - 6, dadurch gekennzeichnet, daß die Expression des exogenen Polypeptids in den Samen der Pflanze erfolgt.40 10. The method according to any one of claims 1-6, characterized in that the expression of the exogenous polypeptide takes place in the seeds of the plant.
Zeichn.Sign.
45 45
11. Expressionskassette für Pflanzen bestehend aus einem Promotor, einem Signalpeptid, einem Gen codierend für die Expression eines exogenen Fungizid-bindenden Polypeptids, einem ER-Retentionssignal und einem Terminator.11. Expression cassette for plants consisting of a promoter, a signal peptide, a gene coding for the expression of an exogenous fungicide-binding polypeptide, an ER retention signal and a terminator.
55
12. Expressionskassette nach Anspruch 11, dadurch gekennzeichnet, daß als konstitutiver Promotor der CaMV 35S-Promotor verwendet wird.12. Expression cassette according to claim 11, characterized in that the CaMV 35S promoter is used as the constitutive promoter.
10 13. Expressionskassette nach Anspruch 11, dadurch gekennzeichnet, daß als zu exprimierendes Gen das Gen eines Einketten-Antikörperfragmentes eingesetzt wird.13 13. Expression cassette according to claim 11, characterized in that the gene of a single-chain antibody fragment is used as the gene to be expressed.
14. Expressionskassette nach Anspruch 11, dadurch gekennzeichnet, 15 daß als zu exprimierendes Gen das Gen oder Genfragment eines Fungizid-bindenden Polypeptides als Translationsfusion mit anderen funktionellen Proteinen wie zum Beispiel Enzymen, To- xinen, Chromophoren und Bindeproteinen eingesetzt wird.14. Expression cassette according to claim 11, characterized in that the gene or gene fragment of a fungicide-binding polypeptide is used as a translation fusion with other functional proteins such as enzymes, toxins, chromophores and binding proteins as the gene to be expressed.
20 15. Expressionskassette nach Anspruch 11, dadurch gekennzeichnet, daß das zu exprimierende Polypeptidgen aus einer Hybridoma- zelle oder mit Hilfe anderer rekombinanter Methoden - wie z.B. der Antikörper-Phage-Display Methode - gewonnen wird.15. Expression cassette according to claim 11, characterized in that the polypeptide gene to be expressed from a hybridoma cell or by means of other recombinant methods - such as e.g. the antibody phage display method - is obtained.
25 16. Verwendung der Expressionskassette nach Anspruch 11 zur25 16. Use of the expression cassette according to claim 11 for
Transformation von dicotylen oder monokotylen Pflanzen, die konstitutiv samen- oder blatt-spezifisch ein exogenes Fungizid-bindendes Polypeptid exprimieren.Transformation of dicotyledonous or monocotyledonous plants which constitutively express an exogenous fungicide-binding polypeptide in a seed- or leaf-specific manner.
30 17. Verwendung nach Anspruch 16, dadurch gekennzeichnet, daß man die Expressionskassette in einen Bakterienstamm transferiert und die entstandenen rekombinanten Klone zur Transformation von dicotylen oder monokotylen Pflanzen, die konstitutiv samen- oder blattspezifisch ein exogenes Fungizid-bindendes17. Use according to claim 16, characterized in that the expression cassette is transferred into a bacterial strain and the resulting recombinant clones for the transformation of dicotyledonous or monocotyledonous plants which are constitutively seed- or leaf-specific, an exogenous fungicide-binding
35 Polypeptid exprimieren, verwendet.35 Express polypeptide used.
18. Verwendung der Expressionskassette nach Anspruch 11 als Se- lektionsmarker .18. Use of the expression cassette according to claim 11 as a selection marker.
40 19. Verwendung einer transformierten Pflanze wie nach Anspruch 17 oder 18 erhalten zur Herstellung eines Fungizid-bindenden Polypeptids.40 19. Use of a transformed plant as claimed in claim 17 or 18 for the preparation of a fungicide-binding polypeptide.
45 45
20. Verfahren zur Transformation einer Pflanze durch Einbringen einer Gensequenz, die für ein Fungizid-bindendes Polypeptid codiert, in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze und Protoplasten von Pflanzenzellen.20. A method for transforming a plant by introducing a gene sequence coding for a fungicide-binding polypeptide into a plant cell, into callus tissue, a whole plant and protoplasts from plant cells.
55
21. Verfahren nach Anspruch 20, dadurch gekennzeichnet, daß die Transformation mit Hilfe eines Agrobacteriums insbesondere der Art Agrobacterium tumefaciens erfolgt.21. The method according to claim 20, characterized in that the transformation is carried out with the aid of an Agrobacterium, in particular the type Agrobacterium tumefaciens.
10 22. Verfahren nach Anspruch 20, dadurch gekennzeichnet, daß die Transformation mit Hilfe der Elektroporation erfolgt.10. The method according to claim 20, characterized in that the transformation is carried out with the aid of electroporation.
23. Verfahren nach Anspruch 20, dadurch gekennzeichnet, daß die Transformation mit Hilfe der particle bombardment Methode er-23. The method according to claim 20, characterized in that the transformation using the particle bombardment method
15 folgt.15 follows.
24. Herstellung eines Fungizid-bindenden Polypeptides durch Expression eines Gens codierend für ein derartiges Polypeptid in einer Pflanze bzw. Zellen einer Pflanze und anschließende24. Production of a fungicide-binding polypeptide by expression of a gene coding for such a polypeptide in a plant or cells of a plant and subsequent
20 Isolierung des Polypeptides.20 Isolation of the polypeptide.
25. Pflanze enthaltend eine Expressionskassette gemäß Anspruch 11, dadurch gekennzeichnet, daß die Expressionskassette Toleranz gegenüber einem Fungizid vermittelt.25. Plant containing an expression cassette according to claim 11, characterized in that the expression cassette imparts tolerance to a fungicide.
2525
26. Pflanze nach Anspruch 25, dadurch gekennzeichnet, daß sie tolerant gegenüber methyl methoxyimino-α- (o-tolyloxy) -o-tolyla- cetate ( BAS 490F ) ist.26. Plant according to claim 25, characterized in that it is tolerant of methyl methoxyimino-α- (o-tolyloxy) -o-tolylacetate (BAS 490F).
30 27. Verfahren zur Bekämpfung von phytopathogenen Pilzen in transgenen Fungizid-toleranten Kulturpflanzen dadurch gekennzeichnet, daß Fungizide eingesetzt werden, gegen die die Kulturpflanze Fungizid-bindende Polypeptide oder Antikörper bildet.30 27. A method for combating phytopathogenic fungi in transgenic fungicide-tolerant crop plants characterized in that fungicides are used against which the crop plant forms fungicide-binding polypeptides or antibodies.
3535
28. Fungizid-bindende Polypeptide bzw. Antikörper mit hoher28. Fungicide-binding polypeptides or antibodies with high
Bindeaffinität zu methyl methoxyimino-α- (o-tolyloxy) -o-toly- lacetate ( BAS 490F ) , dadurch gekennzeichnet, daß sie gemäß Anspruch 24 hergestellt werden. 0Binding affinity to methyl methoxyimino-α- (o-tolyloxy) -o-toly-lacetate (BAS 490F), characterized in that they are prepared according to claim 24. 0
5 Expression von Fungizid-bindenden Polypeptiden in Pflanzen zur Erzeugung von Fungizidtoleranz5 Expression of fungicide-binding polypeptides in plants to produce fungicide tolerance
ZusammenfassungSummary
Verfahren zur Herstellung von Fungizid-toleranten Pflanzen durch Expression eines Fungizid-bindenden Antikörpers in den Pflanzen. Process for the preparation of fungicide-tolerant plants by expression of a fungicide-binding antibody in the plants.
PCT/EP1998/002242 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance WO1998049329A1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
EP98920534A EP0979295A1 (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
SK1372-99A SK137299A3 (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
PL98336661A PL336661A1 (en) 1997-04-30 1998-04-16 Expressions of polypeptides capable to bond fungicides in plants in order to produce fungicid tolerance by plants
AU73356/98A AU737242B2 (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for generating fungicide tolerance
EA199900889A EA199900889A1 (en) 1997-04-30 1998-04-16 EXPRESSION OF CONNECTING FUNGICIDE POLYPEPTIDES IN PLANTS TO OBTAIN THEIR RESISTANCE TO FUNGICIDES
IL13225298A IL132252A0 (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
BR9808698-7A BR9808698A (en) 1997-04-30 1998-04-16 "processes for the production of a methoxyimino-alpha- (o-tolyloxy) -o-tolylacetate-tolerant plant (bas 490f), for the transformation of a plant and to control phytopathogenic fungi in culture plants tolerant to methoxyimino-alpha - Transgenic methyl (o-tolyloxy) -o-tolylacetate (bas 490f) plant expression cassette, plant expression cassette, uses of the expression cassette and a transformed plant, production of a methoxyimino-alpha binding polypeptide - (o-tolyloxy) -o-tolylacetate
CA002288432A CA2288432A1 (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
NZ500181A NZ500181A (en) 1997-04-30 1998-04-16 Production of methyl methoxyimino -alpha-(o-tolyloxy)-o-tolylacetate (BAS 490F)-tolerant plant by expressing the polypeptide
JP54654298A JP2001523101A (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptide in plants to obtain fungicide resistance
BG103840A BG103840A (en) 1997-04-30 1999-10-28 Fungicidebinding polypeptides expression in plants for forming tolerance to fungicides
NO995291A NO995291L (en) 1997-04-30 1999-10-29 Expression of fungicide-binding polypeptides in plants to provide fungicide tolerance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19718251A DE19718251A1 (en) 1997-04-30 1997-04-30 Expression of fungicide-binding polypeptides in plants to produce fungicide tolerance
DE19718251.8 1997-04-30

Publications (1)

Publication Number Publication Date
WO1998049329A1 true WO1998049329A1 (en) 1998-11-05

Family

ID=7828212

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/002242 WO1998049329A1 (en) 1997-04-30 1998-04-16 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance

Country Status (22)

Country Link
EP (1) EP0979295A1 (en)
JP (1) JP2001523101A (en)
KR (1) KR20010020387A (en)
CN (1) CN1254381A (en)
AR (1) AR015626A1 (en)
AU (1) AU737242B2 (en)
BG (1) BG103840A (en)
BR (1) BR9808698A (en)
CA (1) CA2288432A1 (en)
DE (1) DE19718251A1 (en)
EA (1) EA199900889A1 (en)
GE (1) GEP20032959B (en)
HU (1) HUP0003594A3 (en)
ID (1) ID22915A (en)
IL (1) IL132252A0 (en)
NO (1) NO995291L (en)
NZ (1) NZ500181A (en)
PL (1) PL336661A1 (en)
SK (1) SK137299A3 (en)
TR (1) TR199902681T2 (en)
WO (1) WO1998049329A1 (en)
ZA (1) ZA983594B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004020A2 (en) * 2000-07-12 2002-01-17 Mpb Cologne Gmbh Pathogen resistance in organisms

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520962A2 (en) * 1991-06-28 1992-12-30 Ente per le nuove tecnologie, l'energia e l'ambiente ( ENEA) Plasmid vectors for gene expression in plants
WO1994023018A1 (en) * 1993-03-29 1994-10-13 Isk Biosciences Corporation Immunoassay for tetrachloroisophthalonitrile (chlorothalonil®), its derivatives and breakdown products

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520962A2 (en) * 1991-06-28 1992-12-30 Ente per le nuove tecnologie, l'energia e l'ambiente ( ENEA) Plasmid vectors for gene expression in plants
WO1994023018A1 (en) * 1993-03-29 1994-10-13 Isk Biosciences Corporation Immunoassay for tetrachloroisophthalonitrile (chlorothalonil®), its derivatives and breakdown products

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ARTSAENKO, O., ET AL.: "expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco", THE PLANT JOURNAL, vol. 8, no. 5, 1995, pages 745 - 750, XP002074417 *
FIEDLER, U. AND CONRAD, U.: "High-level production and long-term storage of engineered antibodoes in trangenic tobacco seeds", BIOTECHNOLOGY, vol. 13, October 1995 (1995-10-01), pages 1090 - 1093, XP002074416 *
HIATT A ET AL: "ASSEMBLY OF MULTIMERIC PROTEINS IN PLANT CELLS: CHARACTERISTICS AND USES OF PLANT-DERIVED ANTIBODIES", BOOKS IN SOILS PLANTS AND THE ENVIRONMENT: TRANSGENIC PLANTS: FUNDAMENTALS AND APPLICATIONS, 1 January 1993 (1993-01-01), pages 221 - 237, XP000569962 *
SCHOUTEN A ET AL: "THE C-TERMINAL KDEL SEQUENCE INCREASES THE EXPRESSION LEVEL OF A SINGLE-CHAIN ANTIBODY DESIGNED TO BE TARGETED TO BOTH THE CYTOSOL AND THE SECRETORY PATHWAY IN TRANSGENIC TOBACCO", PLANT MOLECULAR BIOLOGY, vol. 30, 1996, pages 781 - 793, XP000677225 *
SWAIN W F: "ANTIBODIES IN PLANTS", TRENDS IN BIOTECHNOLOGY, vol. 9, no. 4, 1 April 1991 (1991-04-01), pages 107 - 109, XP000207981 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004020A2 (en) * 2000-07-12 2002-01-17 Mpb Cologne Gmbh Pathogen resistance in organisms
WO2002004020A3 (en) * 2000-07-12 2002-07-18 Mpb Cologne Gmbh Pathogen resistance in organisms

Also Published As

Publication number Publication date
TR199902681T2 (en) 2000-07-21
NO995291L (en) 1999-12-20
ID22915A (en) 1999-12-16
KR20010020387A (en) 2001-03-15
JP2001523101A (en) 2001-11-20
EP0979295A1 (en) 2000-02-16
IL132252A0 (en) 2001-03-19
BG103840A (en) 2000-07-31
PL336661A1 (en) 2000-07-03
DE19718251A1 (en) 1998-11-05
CA2288432A1 (en) 1998-11-05
HUP0003594A2 (en) 2001-02-28
AU7335698A (en) 1998-11-24
BR9808698A (en) 2000-07-11
HUP0003594A3 (en) 2002-10-28
AU737242B2 (en) 2001-08-16
ZA983594B (en) 1999-10-29
GEP20032959B (en) 2003-04-25
NZ500181A (en) 2001-02-23
AR015626A1 (en) 2001-05-16
SK137299A3 (en) 2000-05-16
CN1254381A (en) 2000-05-24
NO995291D0 (en) 1999-10-29
EA199900889A1 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
DE69637402T2 (en) CHIMAIR GENE, CONTAINING A HYDROXY-PHENYLPYRUVATE DIOXYGENASE GENE ENCODING DNA SEQUENCE, AND PRODUCING THESE HERBICIDE RESISTANCES CONTAINING
DE69933713T2 (en) Corn alpha-tubulin 3-18 promoter
DE60221051T2 (en) PREPARATION OF PEPTIDES AND PROTEINS BY TREATMENT IN PROTEIN BODIES DERIVED FROM ENDOPLASMIC RETICULUM
Negrouk et al. Highly efficient transient expression of functional recombinant antibodies in lettuce
DE102010013166A1 (en) Method for increasing the yield of semen and promoting the growth of plants
DE69924005T2 (en) TRANSGENIC PLANTS WITH CONDITIONAL LETHAL GEN
WO1997029200A1 (en) Cassettes for the expression of storable proteins in plants
US5990385A (en) Protein production in transgenic alfalfa plants
WO1998049329A1 (en) Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
DE69938144T2 (en) ANTIBODY-MEDIATED DERIVATION REGULATION OF PLANT PROTEINS
EP0970231A1 (en) Expression of herbicide-binding polypeptides in plants to produce herbicide tolerance
US20120042416A1 (en) Antibody fusion-mediated plant resistance against Oomycota
DE10049267B4 (en) Method for producing or increasing resistance in organisms to biotic stress factors
DE60314017T2 (en) CHIMERIC PROTEIN CONTAINS THE CYSTEIN PROTEASE FROM THE LARGE LIVERGEL FUSIONED TO THE HEPATITIS B CORE PROTEIN OR UBIQUITIN; PLANTS EXPRESSING THIS PROTEIN, AND THEIR USE AS VACCINE
WO2003041493A1 (en) Production of recombinant antibodies by means of fusion with elastin-like peptides
DE10145969A1 (en) Method for producing a marker vaccine against a mammalian virus
CZ382199A3 (en) Production of plants being tolerant to fungicides due to expression of polypeptides binding fungicides in plant
Mavituna Production of recombinant human serum albumin in transgenic plants and plant cells
DE10063879B4 (en) Nucleic acids encoding vacuolar invertases, plant cells and plants containing them and their use
KR0155453B1 (en) Method of combined antibody against hepatitis-b virus by nicotiana tabacum
Junco et al. International application published under the patent cooperation treaty (PCT)
EP1029064A1 (en) Protein production in transgenic alfalfa plants
JP2001521756A5 (en)
DE19604588A1 (en) Cassette for expressing storage-stable proteins in plants
JPH06233685A (en) Peptide gene of flower bud-inducing substance

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 132252

Country of ref document: IL

Ref document number: 98804679.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AU BG BR BY CA CN CZ GE HU ID IL JP KR KZ LT LV MX NO NZ PL RO RU SG SI SK TR UA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 137299

Country of ref document: SK

Ref document number: 1998920534

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 500181

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/009498

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 09403654

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2288432

Country of ref document: CA

Ref document number: 2288432

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1999-3821

Country of ref document: CZ

Ref document number: 1999/02681

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 1998 546542

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1019997010009

Country of ref document: KR

Ref document number: 73356/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 199900889

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1998920534

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1999-3821

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019997010009

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 73356/98

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1998920534

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1019997010009

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1999-3821

Country of ref document: CZ